{"SLR NAME":"Gastrointestinal symptoms and fecal nucleic acid testing of children with 2019 coronavirus disease: a systematic review and meta-analysis","References":[{"title1":"Clinical and CT features in pediatric patients with COVID?19 infection: Different points from adults","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020","References":[{"title3":"World Health Organization (WHO). Pneumonia of unknown cause - China. Geneva: WHO; 2020."},{"title3":"World Health Organization (WHO). Novel Coronavirus - China. Geneva: WHO; 2020."},{"title3":"European Centre for Disease Prevention and Control (ECDC). Outbreak of acute respiratory syndrome associated with a novel coronavirus, China; First cases imported in the EU/EEA; second update - 26 January 2020. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Risk-assessment-pneumonia-Wuhan-China-26-Jan-2020_0.pdf "},{"title3":"Mobs Lab. Situation report Mainland China dashboard. [Accessed 27 Jan 2020]. Available from: https://docs.google.com/spreadsheets/d/e/2PACX-1vQU0SIALScXx8VXDX7yKNKWWPKE1YjFlWc6VTEVSN45CklWWf-uWmprQIyLtoPDA18tX9cFDr-aQ9S6/pubhtml "},{"title3":"Johns Hopkins University Center for Systems Science and Engineering. Wuhan Coronavirus (2019-nCoV) Global Cases, January 27, 2020, 9am EST. [Accessed 27 Jan 2020]. Available from: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 "},{"title3":"Australian Government, Department of Health. Update on novel coronavirus, Jan 28, 2020. [Accessed 30 Jan 2020]. Available from: https://www.health.gov.au/news/update-on-novel-coronavirus "},{"title3":"Korea Centers for Disease Control &amp; Prevention. The fourth imported case of 2019 novel coronavirus(2019-nCoV) has been confirmed in Korea. 27 Jan 2020. [Accessed 27 Jan 2020]. Available from: https://www.cdc.go.kr/board/board.es?mid=a30402000000&amp;bid=0030 "},{"title3":"European Centre for Disease Prevention and Control (ECDC). ECDC statement following reported confirmed case of 2019-nCoV in Germany. 28 Jan 2020. Stockholm: ECDC. [Accessed 30 Jan 2020]. Available from: https://www.ecdc.europa.eu/en/news-events/ecdc-statement-following-reported-confirmed-case-2019-ncov-germany "},{"title3":"China halts flights and trains out of Wuhan as WHO extends talks. Channel News Asia. 26 Jan 2020. [Accessed 26 Jan 2020]. Available from: https://www.channelnewsasia.com/news/asia/wuhan-virus-quarantine-city-flights-trains-china-12306684?cid=h3_referral_inarticlelinks_24082018_cna "},{"title3":"Wikipedia. the free encyclopedia. St. Petersburg (FL): Wikimedia Foundation, Inc. 2001 - Europe; contemporary definition. [Modified 28 Jan 2020; Accessed 28 Jan 2020]. Available from: https://en.wikipedia.org/wiki/Europe#Definition "},{"title3":"  Available from: https://epirisk.net/ "},{"title3":"Chinazzi M, Davis JT, Gioannini C, Litvinova M, Pastore y Piontti A, Rossi L, et al. Preliminary assessment of the International Spreading Risk Associated with the 2019 novel Coronavirus (2019-nCoV) outbreak in Wuhan City. Available from:  https://www.mobs-lab.org/uploads/6/7/8/7/6787877/wuhan_novel_coronavirus__6_.pdf "},{"title3":"  Available from: https://www.gleamproject.org/ "},{"title3":"Lai S, Bogoch II, Watts A, Khan K, Li Z, Tatem A. Preliminary risk analysis of 2019 novel coronavirus spread within and beyond China. Available from: https://www.worldpop.org/resources/docs/china/WorldPop-coronavirus-spread-risk-analysis-v1-25Jan.pdf "},{"title3":"Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel."}]},{"title2":"General Office of the National Health Commission of China. Diagnosis and Treatment Protocol for 2019-nCoV. 5th ed. Beijing, China: National Health Commission of China; 2020.","References":[]},{"title2":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city","References":[]},{"title2":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020","References":[{"title3":"World Health Organization (WHO). Pneumonia of unknown cause - China. Geneva: WHO; 2020. Available from: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/ "},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.."},{"title3":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv. 2020;10.1101/2020.01.22.914952. Available from: https://www.biorxiv.org/content/early/2020/01/23/2020.01.22.914952 "},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"World Health Organization (WHO). Novel Coronavirus (2019-nCoV) situation report 9. Geneva: WHO; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200129-sitrep-9-ncov-v2.pdf?sfvrsn=e2c8915_2 "},{"title3":"Imai N, Dorigatti I, Cori A, Donnelly C, Riley S, Ferguson NM. Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China. London: Imperial College; 2020. Available from: https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/ "},{"title3":"Superspreading and the effect of individual variation on disease emergence."},{"title3":"Ebola superspreading."},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission."},{"title3":"Rambaut A. Preliminary phylogenetic analysis of 11 nCoV2019 genomes, 2020-01-19. ARTIC Network; 2020. Available from: http://virological.org/t/preliminary-phylogenetic-analysis-of-11-ncov2019-genomes-2020-01-19/329 "},{"title3":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2018. Available from: http://www.R-project.org/"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk."},{"title3":"Effectiveness of control measures during the SARS epidemic in Beijing: a comparison of the Rt curve and the epidemic curve."},{"title3":"Influenza transmission in households during the 1918 pandemic."},{"title3":"Middle EAST respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015."},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus."}]},{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health:the latest 2019 novel coronavirus outbreak in Wuhan, China","References":[{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"Pneumonia in China: lack of information raises concerns among Hong Kong health workers"},{"title3":"Taking forward a' One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential"},{"title3":"ProMED &quot;Novel coronavirus - China (01): (HU) WHO, phylogenetic tree&quot;. Archive Number: 20200112.6885385. Accessed 13 Jan 2020. https://www.ecohealthalliance.org/2020/01/phylogenetic-analysis-shows-novel-wuhan-coronavirus-clusters-with-sars."}]},{"title2":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia","References":[]},{"title2":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis","References":[]},{"title2":"Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist","References":[{"title3":"A Novel Coronavirus from Patients with Pneumonia in China"},{"title3":"Geneva, Switzerland: World Health Organization"},{"title3":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission"},{"title3":"SARS: imaging of severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients"},{"title3":"Acute Middle East Respiratory Syndrome Coronavirus: Temporal Lung Changes Observed on the Chest Radiographs of 55 Patients"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Acute respiratory distress syndrome: CT abnormalities at long-term follow-up"},{"title3":"Acute respiratory distress syndrome: imaging of the injured lung"}]},{"title2":"Emerging coronavirus 2019-nCoV pneumonia","References":[]},{"title2":"Differentiation of bacterial and viral pneumonia in children","References":[{"title3":"Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: An updated systematic analysis"},{"title3":"Differentiation of bacterial and viral pneumonia in children"},{"title3":"Problems in determining the etiology of community-acquired childhood pneumonia"},{"title3":"Accuracy of radiographic differentiation of bacterial from nonbacterial pneumonia"},{"title3":"Point-of-care lung ultrasound in children with community acquired pneumonia"},{"title3":"Performance of chest ultrasound in pediatric pneumonia"},{"title3":"Lung Ultrasonography: A Viable Alternative to Chest Radiography in Children with Suspected Pneumonia?"},{"title3":"Feasibility and Safety of Substituting Lung Ultrasonography for Chest Radiography When Diagnosing Pneumonia in Children: A Randomized Controlled Trial"},{"title3":"Lung ultrasound in diagnosis and follow up of community acquired pneumonia in infants younger than 1-year old"},{"title3":"Lung Ultrasonography Beyond the Diagnosis of Pediatrics Pneumonia"},{"title3":"Usefulness of lung ultrasound in the diagnosis of community-acquired pneumonia in children"},{"title3":"Can lung ultrasound replace chest radiography for the diagnosis of pneumonia in hospitalized children?"},{"title3":"Point-of-care lung ultrasound in young children with respiratory tract infections and wheeze"},{"title3":"Salivary C-reactive protein and mean platelet volume in diagnosis of late-onset neonatal pneumonia"},{"title3":"Salivary C-Reactive Protein and Mean Platelet Volume in the Diagnosis and Follow-Up of Community-Acquired Pneumonia in Infants"},{"title3":"The value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in differentiating pneumonia from upper respiratory tract infection (URTI) in children: A cross-sectional study"},{"title3":"Value of Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Red Blood Cell Distribution Width in Evaluating the Prognosis of Children with Severe Pneumonia"},{"title3":"Neutrophil/lymphocyte and C-reactive protein/mean platelet volume ratios in differentiating between viral and bacterial pneumonias and diagnosing early complications in children"},{"title3":"Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa"},{"title3":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: Update 2011"},{"title3":"Ultrasound diagnosis of pneumonia in children"},{"title3":"Lung ultrasound characteristics of community-acquired pneumonia in hospitalized children"},{"title3":"Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections"},{"title3":"Diagnostic performance of the Sputum Gram Stain in predicting sputum culture results for critically ill pediatric patients with pneumonia"},{"title3":"Sputum Gram Stain for Bacterial Pathogen Diagnosis in Community-acquired Pneumonia: A Systematic Review and Bayesian Meta-analysis of Diagnostic Accuracy and Yield"},{"title3":"Lung ultrasound in the diagnosis of pneumonia in children: Proposal for a new diagnostic algorithm"},{"title3":"Prospective evaluation of point-of-care ultrasonography for the diagnosis of pneumonia in children and young adults"},{"title3":"Performance of lung ultrasonography in children with community-acquired pneumonia"},{"title3":"Lung ultrasound for the diagnosis of pneumonia in children: A meta-analysis"},{"title3":"Can lung ultrasound differentiate between bacterial and viral pneumonia in children?"},{"title3":"The Usefulness of Lung Ultrasound for the Aetiological Diagnosis of Community-Acquired Pneumonia in Children"},{"title3":"Prospective application of clinician performed lung ultrasonography during the 2009 H1N1 influenza A pandemic: Distinguishing viral from bacterial pneumonia"},{"title3":"Lung ultrasound in bronchiolitis: Comparison with chest X-ray"},{"title3":"Lung ultrasound: A useful tool in diagnosis and management of bronchiolitis"},{"title3":"Radiological perspectives in empyema"},{"title3":"Ultrasound characteristics of community acquired pneumonia in children"},{"title3":"Salivary C-reactive protein, mean platelet volume and neutrophil lymphocyte ratio as diagnostic markers for neonatal sepsis"},{"title3":"Age- and sex-specific pediatric reference intervals for neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio"},{"title3":"Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease"},{"title3":"What is the normal value of the neutrophil-to-lymphocyte ratio?"},{"title3":"Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients"},{"title3":"Diagnostic accuracy of lung ultrasonography combined with procalcitonin for the diagnosis of pneumonia: A pilot study"}]}]},{"title1":"Clinical and CT features in pediatric patients with COVID?19 infection: Different points from adults","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020","References":[{"title3":"World Health Organization (WHO). Pneumonia of unknown cause - China. Geneva: WHO; 2020."},{"title3":"World Health Organization (WHO). Novel Coronavirus - China. Geneva: WHO; 2020."},{"title3":"European Centre for Disease Prevention and Control (ECDC). Outbreak of acute respiratory syndrome associated with a novel coronavirus, China; First cases imported in the EU/EEA; second update - 26 January 2020. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Risk-assessment-pneumonia-Wuhan-China-26-Jan-2020_0.pdf "},{"title3":"Mobs Lab. Situation report Mainland China dashboard. [Accessed 27 Jan 2020]. Available from: https://docs.google.com/spreadsheets/d/e/2PACX-1vQU0SIALScXx8VXDX7yKNKWWPKE1YjFlWc6VTEVSN45CklWWf-uWmprQIyLtoPDA18tX9cFDr-aQ9S6/pubhtml "},{"title3":"Johns Hopkins University Center for Systems Science and Engineering. Wuhan Coronavirus (2019-nCoV) Global Cases, January 27, 2020, 9am EST. [Accessed 27 Jan 2020]. Available from: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 "},{"title3":"Australian Government, Department of Health. Update on novel coronavirus, Jan 28, 2020. [Accessed 30 Jan 2020]. Available from: https://www.health.gov.au/news/update-on-novel-coronavirus "},{"title3":"Korea Centers for Disease Control &amp; Prevention. The fourth imported case of 2019 novel coronavirus(2019-nCoV) has been confirmed in Korea. 27 Jan 2020. [Accessed 27 Jan 2020]. Available from: https://www.cdc.go.kr/board/board.es?mid=a30402000000&amp;bid=0030 "},{"title3":"European Centre for Disease Prevention and Control (ECDC). ECDC statement following reported confirmed case of 2019-nCoV in Germany. 28 Jan 2020. Stockholm: ECDC. [Accessed 30 Jan 2020]. Available from: https://www.ecdc.europa.eu/en/news-events/ecdc-statement-following-reported-confirmed-case-2019-ncov-germany "},{"title3":"China halts flights and trains out of Wuhan as WHO extends talks. Channel News Asia. 26 Jan 2020. [Accessed 26 Jan 2020]. Available from: https://www.channelnewsasia.com/news/asia/wuhan-virus-quarantine-city-flights-trains-china-12306684?cid=h3_referral_inarticlelinks_24082018_cna "},{"title3":"Wikipedia. the free encyclopedia. St. Petersburg (FL): Wikimedia Foundation, Inc. 2001 - Europe; contemporary definition. [Modified 28 Jan 2020; Accessed 28 Jan 2020]. Available from: https://en.wikipedia.org/wiki/Europe#Definition "},{"title3":"  Available from: https://epirisk.net/ "},{"title3":"Chinazzi M, Davis JT, Gioannini C, Litvinova M, Pastore y Piontti A, Rossi L, et al. Preliminary assessment of the International Spreading Risk Associated with the 2019 novel Coronavirus (2019-nCoV) outbreak in Wuhan City. Available from:  https://www.mobs-lab.org/uploads/6/7/8/7/6787877/wuhan_novel_coronavirus__6_.pdf "},{"title3":"  Available from: https://www.gleamproject.org/ "},{"title3":"Lai S, Bogoch II, Watts A, Khan K, Li Z, Tatem A. Preliminary risk analysis of 2019 novel coronavirus spread within and beyond China. Available from: https://www.worldpop.org/resources/docs/china/WorldPop-coronavirus-spread-risk-analysis-v1-25Jan.pdf "},{"title3":"Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel."}]},{"title2":"General Office of the National Health Commission of China. Diagnosis and Treatment Protocol for 2019-nCoV. 5th ed. Beijing, China: National Health Commission of China; 2020.","References":[]},{"title2":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city","References":[]},{"title2":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020","References":[{"title3":"World Health Organization (WHO). Pneumonia of unknown cause - China. Geneva: WHO; 2020. Available from: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/ "},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.."},{"title3":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv. 2020;10.1101/2020.01.22.914952. Available from: https://www.biorxiv.org/content/early/2020/01/23/2020.01.22.914952 "},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"World Health Organization (WHO). Novel Coronavirus (2019-nCoV) situation report 9. Geneva: WHO; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200129-sitrep-9-ncov-v2.pdf?sfvrsn=e2c8915_2 "},{"title3":"Imai N, Dorigatti I, Cori A, Donnelly C, Riley S, Ferguson NM. Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China. London: Imperial College; 2020. Available from: https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/ "},{"title3":"Superspreading and the effect of individual variation on disease emergence."},{"title3":"Ebola superspreading."},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission."},{"title3":"Rambaut A. Preliminary phylogenetic analysis of 11 nCoV2019 genomes, 2020-01-19. ARTIC Network; 2020. Available from: http://virological.org/t/preliminary-phylogenetic-analysis-of-11-ncov2019-genomes-2020-01-19/329 "},{"title3":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2018. Available from: http://www.R-project.org/"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk."},{"title3":"Effectiveness of control measures during the SARS epidemic in Beijing: a comparison of the Rt curve and the epidemic curve."},{"title3":"Influenza transmission in households during the 1918 pandemic."},{"title3":"Middle EAST respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015."},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus."}]},{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health:the latest 2019 novel coronavirus outbreak in Wuhan, China","References":[{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"Pneumonia in China: lack of information raises concerns among Hong Kong health workers"},{"title3":"Taking forward a' One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential"},{"title3":"ProMED &quot;Novel coronavirus - China (01): (HU) WHO, phylogenetic tree&quot;. Archive Number: 20200112.6885385. Accessed 13 Jan 2020. https://www.ecohealthalliance.org/2020/01/phylogenetic-analysis-shows-novel-wuhan-coronavirus-clusters-with-sars."}]},{"title2":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia","References":[]},{"title2":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis","References":[]},{"title2":"Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist","References":[{"title3":"A Novel Coronavirus from Patients with Pneumonia in China"},{"title3":"Geneva, Switzerland: World Health Organization"},{"title3":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission"},{"title3":"SARS: imaging of severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients"},{"title3":"Acute Middle East Respiratory Syndrome Coronavirus: Temporal Lung Changes Observed on the Chest Radiographs of 55 Patients"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Acute respiratory distress syndrome: CT abnormalities at long-term follow-up"},{"title3":"Acute respiratory distress syndrome: imaging of the injured lung"}]},{"title2":"Emerging coronavirus 2019-nCoV pneumonia","References":[]},{"title2":"Differentiation of bacterial and viral pneumonia in children","References":[{"title3":"Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: An updated systematic analysis"},{"title3":"Differentiation of bacterial and viral pneumonia in children"},{"title3":"Problems in determining the etiology of community-acquired childhood pneumonia"},{"title3":"Accuracy of radiographic differentiation of bacterial from nonbacterial pneumonia"},{"title3":"Point-of-care lung ultrasound in children with community acquired pneumonia"},{"title3":"Performance of chest ultrasound in pediatric pneumonia"},{"title3":"Lung Ultrasonography: A Viable Alternative to Chest Radiography in Children with Suspected Pneumonia?"},{"title3":"Feasibility and Safety of Substituting Lung Ultrasonography for Chest Radiography When Diagnosing Pneumonia in Children: A Randomized Controlled Trial"},{"title3":"Lung ultrasound in diagnosis and follow up of community acquired pneumonia in infants younger than 1-year old"},{"title3":"Lung Ultrasonography Beyond the Diagnosis of Pediatrics Pneumonia"},{"title3":"Usefulness of lung ultrasound in the diagnosis of community-acquired pneumonia in children"},{"title3":"Can lung ultrasound replace chest radiography for the diagnosis of pneumonia in hospitalized children?"},{"title3":"Point-of-care lung ultrasound in young children with respiratory tract infections and wheeze"},{"title3":"Salivary C-reactive protein and mean platelet volume in diagnosis of late-onset neonatal pneumonia"},{"title3":"Salivary C-Reactive Protein and Mean Platelet Volume in the Diagnosis and Follow-Up of Community-Acquired Pneumonia in Infants"},{"title3":"The value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in differentiating pneumonia from upper respiratory tract infection (URTI) in children: A cross-sectional study"},{"title3":"Value of Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Red Blood Cell Distribution Width in Evaluating the Prognosis of Children with Severe Pneumonia"},{"title3":"Neutrophil/lymphocyte and C-reactive protein/mean platelet volume ratios in differentiating between viral and bacterial pneumonias and diagnosing early complications in children"},{"title3":"Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa"},{"title3":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: Update 2011"},{"title3":"Ultrasound diagnosis of pneumonia in children"},{"title3":"Lung ultrasound characteristics of community-acquired pneumonia in hospitalized children"},{"title3":"Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections"},{"title3":"Diagnostic performance of the Sputum Gram Stain in predicting sputum culture results for critically ill pediatric patients with pneumonia"},{"title3":"Sputum Gram Stain for Bacterial Pathogen Diagnosis in Community-acquired Pneumonia: A Systematic Review and Bayesian Meta-analysis of Diagnostic Accuracy and Yield"},{"title3":"Lung ultrasound in the diagnosis of pneumonia in children: Proposal for a new diagnostic algorithm"},{"title3":"Prospective evaluation of point-of-care ultrasonography for the diagnosis of pneumonia in children and young adults"},{"title3":"Performance of lung ultrasonography in children with community-acquired pneumonia"},{"title3":"Lung ultrasound for the diagnosis of pneumonia in children: A meta-analysis"},{"title3":"Can lung ultrasound differentiate between bacterial and viral pneumonia in children?"},{"title3":"The Usefulness of Lung Ultrasound for the Aetiological Diagnosis of Community-Acquired Pneumonia in Children"},{"title3":"Prospective application of clinician performed lung ultrasonography during the 2009 H1N1 influenza A pandemic: Distinguishing viral from bacterial pneumonia"},{"title3":"Lung ultrasound in bronchiolitis: Comparison with chest X-ray"},{"title3":"Lung ultrasound: A useful tool in diagnosis and management of bronchiolitis"},{"title3":"Radiological perspectives in empyema"},{"title3":"Ultrasound characteristics of community acquired pneumonia in children"},{"title3":"Salivary C-reactive protein, mean platelet volume and neutrophil lymphocyte ratio as diagnostic markers for neonatal sepsis"},{"title3":"Age- and sex-specific pediatric reference intervals for neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio"},{"title3":"Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease"},{"title3":"What is the normal value of the neutrophil-to-lymphocyte ratio?"},{"title3":"Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients"},{"title3":"Diagnostic accuracy of lung ultrasonography combined with procalcitonin for the diagnosis of pneumonia: A pilot study"}]}]},{"title1":"Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study","References":[{"title2":"The UK has approved a COVID vaccine:here's what scientists now want to know","References":[]},{"title2":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","References":[{"title3":"An mRNA vaccine against SARS-CoV-2 : preliminary report."},{"title3":"Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine."},{"title3":"Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates."},{"title3":"Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults."},{"title3":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial."},{"title3":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial."},{"title3":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial."},{"title3":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial."},{"title3":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK."},{"title3":"Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design."},{"title3":"Review of current vaccine development strategies to prevent coronavirus disease 2019 (COVID-19)."},{"title3":"Developing Covid-19 vaccines at pandemic speed."},{"title3":"The COVID-19 vaccine development landscape."},{"title3":"SARS-CoV-2 mRNA vaccine development enabled by prototype pathogen preparedness."},{"title3":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates."},{"title3":"Safety and efficacy of the BNT162b2 Covid-19 vaccine"},{"title3":"Enhancing the diversity of clinical trial populations : eligibility criteria, enrollment practices, and trial designs: guidance for industry"},{"title3":"Coronavirus disease 2019 (COVID 19)."},{"title3":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis."},{"title3":"Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination."},{"title3":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older."},{"title3":"Adjuvanted herpes zoster subunit vaccine in older adults."},{"title3":"Immunization with inactivated Middle East respiratory syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus."},{"title3":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge."},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus."},{"title3":"NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge."},{"title3":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques."},{"title3":"A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates."}]},{"title2":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","References":[{"title3":"Factors associated with COVID-19-related death using OpenSAFELY"},{"title3":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study"},{"title3":"Martin-Moro F, Marquet J, Piris M, Michael BM, Saez AJ, Corona M, Jimenez C, Astibia B, Garcia I, Rodriguez E, Garcia-Hoz C, Fortun-Abete J, Herrera P, Lopez-Jimenez J (2020) Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol 190(1):e16-e20. 10.1111/bjh.16801"},{"title3":"Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients"},{"title3":"A dynamic COVID-19 immune signature includes associations with poor prognosis"},{"title3":"Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution"},{"title3":"Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study"},{"title3":"Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment"}]},{"title2":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","References":[{"title3":"WHO coronavirus disease (COVID-19) dashboard"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study"},{"title3":"DRAFT landscape of COVID-19 candidate vaccines:20 March 2020"},{"title3":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial"},{"title3":"Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine administered in a prime-boost regimen in older adults (COV002): a phase 2/3 single blind, randomised controlled trial"},{"title3":"Barret JR, Belij-Rammerstorfer S. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. Nat Med (in press)."},{"title3":"A minimal common outcome measure set for COVID-19 clinical research"},{"title3":"A modified Poisson regression approach to prospective studies with binary data"},{"title3":"Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial"},{"title3":"Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study"},{"title3":"The first interim data analysis of the Sputnik V vaccine against COVID-19 phase III clinical trials in the Russian Federation demonstrated 92% efficacy"},{"title3":"Moderna's COVID-19 vaccine candidate meets its primary efficacy endpoint in the first interim analysis of the phase 3 COVE study"},{"title3":"Development and licensure of vaccines to prevent COVID-19"},{"title3":"WHO target product profiles for COVID-19 vaccines"},{"title3":"Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention"},{"title3":"WHO COVID-19 case definition"},{"title3":"COVID-19: investigation and initial clinical management of possible cases"},{"title3":"COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland"},{"title3":"Ethnicity and clinical outcomes in COVID-19: a systematic Review and Meta-analysis"}]},{"title2":"People who have received 1st dose vaccinations, by report date","References":[]},{"title2":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","References":[{"title3":"COVID-19 vaccination programme"},{"title3":"Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI, 30 December 2020"},{"title3":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine"},{"title3":"BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting"},{"title3":"Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of &quot;real-world&quot; vaccination outcomes from Israel"},{"title3":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK"},{"title3":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial"},{"title3":"Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials"},{"title3":"COVID-19: vaccine surveillance strategy"},{"title3":"Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23 4 million patients using OpenSAFELY"},{"title3":"Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England"},{"title3":"Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study"},{"title3":"COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study"},{"title3":"Real-time tracking of self-reported symptoms to predict potential COVID-19"},{"title3":"Rapid implementation of mobile technology for real-time epidemiology of COVID-19"},{"title3":"Coronavirus (COVID-19) Infection Survey"},{"title3":"Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application: a prospective, observational study"},{"title3":"Accessible data curation and analytics for international-scale citizen science datasets"},{"title3":"English indices of deprivation 2019"},{"title3":"Single dose vaccination in healthcare workers previously infected with SARS-CoV-2"},{"title3":"Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine"},{"title3":"COVID-19: people who have had infection might only need one dose of mRNA vaccine"},{"title3":"Population estimates for the UK, England and Wales, Scotland and Northern Ireland, provisional: mid-2019"},{"title3":"Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals"},{"title3":"The effectiveness of the first dose of BNT162b2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence"},{"title3":"Determinants of participants' follow-up and characterization of representativeness in flu near you, a participatory disease surveillance system"},{"title3":"Geo-social gradients in predicted COVID-19 prevalence in Great Britain: results from 1 960 242 users of the COVID-19 Symptoms Study app"},{"title3":"Collider bias undermines our understanding of COVID-19 disease risk and severity"}]},{"title2":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study","References":[{"title3":"Vaccine BNT162b2: conditions of authorisation under Regulation 174"},{"title3":"Public Health England. National flu and COVID-19 surveillance report: 21 January 2021 (week 3). 2020. www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports "},{"title3":"Department of Health and Social Care. Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination, 30 December 2020. www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020#contents "},{"title3":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine"},{"title3":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK"},{"title3":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine"},{"title3":"Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect"},{"title3":"A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks"},{"title3":"Public Health England. Investigation of novel SARS-COV-2 variant - Variant of Concern 202012/01 2020. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/947048/Technical_Briefing_VOC_SH_NJL2_SH2.pdf "},{"title3":"Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England."},{"title3":"Public Health England. Investigation of novel SARS-CoV-2 variant - Variant of Concern 202012/01 - Technical briefing 4. 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/952490/Variant_of_Concern_VOC_202012_01_Technical_Briefing_4_England.pdf "},{"title3":"European Centre for Disease Prevention and Control. Threat Assessment Brief: Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom. 20 December 2020. www.ecdc.europa.eu/sites/default/files/documents/SARS-CoV-2-variant-multiple-spike-protein-mutations-United-Kingdom.pdf "},{"title3":"World Health Organization. Design of vaccine efficacy trials to be used during public health emergencies:points of considerations and key principles. 2020."},{"title3":"Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season"},{"title3":"End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18"},{"title3":"The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials"},{"title3":"Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design"},{"title3":"Department of Health and Social Care. COVID-19 testing data: methodology note. 2020. www.gov.uk/government/publications/coronavirus-covid-19-testing-data-methodology/covid-19-testing-data-methodology-note "},{"title3":"Public Health England. Investigation of novel SARS-CoV-2 variants of concern in England - Technical briefing 6. 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/961299/Variants_of_Concern_VOC_Technical_Briefing_6_England-1.pdf "},{"title3":"Public Health England. Technical summary: Public Health England data series on deaths in people with COVID-19. 2020. www.gov.uk/government/publications/phe-data-series-on-deaths-in-people-with-covid-19-technical-summary "},{"title3":"Care Quality Commission. CQC care directory. 2021. www.cqc.org.uk/files/cqc-care-directory-zip "},{"title3":"Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020"},{"title3":"Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates"},{"title3":"Ramsay M. COVID-19: the green book, chapter 14a. Immunisation against infectious diseases: Public Health England. 2020."},{"title3":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial"},{"title3":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial"},{"title3":"Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine."},{"title3":"Joint Committee on Vaccination and Immunisation. Optimising the COVID-19 vaccination programme for maximum short-term impact 2021. www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement/optimising-the-covid-19-vaccination-programme-for-maximum-short-term-impact "},{"title3":"The effectiveness of the first dose of BNT162b2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence."},{"title3":"Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of 'real-world' vaccination outcomes from Israel."},{"title3":"Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients"},{"title3":"Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera."},{"title3":"Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera."}]},{"title2":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","References":[{"title3":"COVID-19 coronavirus pandemic"},{"title3":"COVID-19 database (in Hebrew)"},{"title3":"SARS-CoV-2 vaccines and the growing threat of viral variants"},{"title3":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine"},{"title3":"Coronavirus (COVID-19) vaccinations"},{"title3":"Vaccine effectiveness after 1st and 2nd dose of the BNT162b2 mRNA COVID-19 vaccine in long-term care facility residents and healthcare workers:a Danish cohort study"},{"title3":"Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients"},{"title3":"The effectiveness of the first dose of BNT162b2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence"},{"title3":"Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study"},{"title3":"COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study"},{"title3":"Effectiveness of the Pfizer-BioNTech COVID-19 vaccine among residents of two skilled nursing facilities experiencing COVID-19 outbreaks:Connecticut, December 2020-February 2021"},{"title3":"BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting"},{"title3":"Rights of the insured under the national health insurance law"},{"title3":"Calculation of the key to the distribution of health insurance funds between the health funds as of February 1, 2021"},{"title3":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies"},{"title3":"Investigation of novel SARS-CoV-2 variant: variant of concern 202012/01"},{"title3":"Comprehensive analyses of SARS-CoV-2 transmission in a public health virology laboratory"},{"title3":"COVID-19 treatment guidelines: clinical spectrum of SARS-CoV-2 infection"},{"title3":"Negative binomial mixed models for analyzing microbiome count data"},{"title3":"Regression models with count data"},{"title3":"Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera"},{"title3":"Israeli Health Ministry reports four cases of South African COVID-19 variant"},{"title3":"Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults"},{"title3":"Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic"},{"title3":"&quot;Herd immunity&quot;: a rough guide"},{"title3":"Reopening society and the need for real-time assessment of COVID-19 at the community level"}]},{"title2":"Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study","References":[{"title3":"Investigation of novel SARS-COV-2 variant: variant of concern 202012/01. Technical briefing 1"},{"title3":"Investigation of novel SARS-COV-2 variant: variant of concern 202012/01. Technical briefing 2"},{"title3":"Genomic sequencing in pandemics"},{"title3":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"on SARS-CoV-2 variant B.1.1.7. NERVTAG: update note on B.1.1.7 severity"},{"title3":"Rapid implementation of mobile technology for real-time epidemiology of COVID-19"},{"title3":"An integrated national scale SARS-CoV-2 genomic surveillance network"},{"title3":"Investigation of novel SARS-COV-2 variant: variant of concern 202012/01. Technical briefing 3"},{"title3":"Attributes and predictors of long COVID"},{"title3":"Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application: a prospective, observational study"},{"title3":"UK COVID-19 dashboard"},{"title3":"Increased infections, but not viral burden, with a new SARS-CoV-2 variant"},{"title3":"Coronavirus (COVID-19) Infection Survey: characteristics of people testing positive for COVID-19 in England"},{"title3":"Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2"},{"title3":"Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020"},{"title3":"Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera"},{"title3":"mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants"},{"title3":"Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera"},{"title3":"Rapid review of available evidence on the serial interval and generation time of COVID-19"},{"title3":"Coronavirus (COVID-19):the R value and growth rate in the UK"},{"title3":"Coronavirus (COVID-19) Infection Survey: antibody data for the UK"},{"title3":"Public health actions to control new SARS-CoV-2 variants"},{"title3":"Variants: distribution of cases data"},{"title3":"Determinants of participants' follow-up and characterization of representativeness in flu near you, a participatory disease surveillance system"},{"title3":"Collider bias undermines our understanding of COVID-19 disease risk and severity"},{"title3":"Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: a prospective cohort study"},{"title3":"Effects of environmental factors on severity and mortality of COVID-19"}]},{"title2":"Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals","References":[{"title3":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting"},{"title3":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine"},{"title3":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7"},{"title3":"Tegally, H. et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. Preprint at medRxiv10.1101/2020.12.21.20248640 (2020)."},{"title3":"Naveca, F. et al. Phylogenetic relationship of SARS-CoV-2 sequences from Amazonas with emerging Brazilian variants harboring mutations E484K and N501Y in the Spike protein. Virological.orghttps://virological.org/t/phylogenetic-relationship-of-sars-cov-2- sequences-from-amazonas-with-emerging- brazilian-variants-harboring-mutations- e484k-and-n501y-in-the-spike-protein/585 (2021)."},{"title3":"Neutralizing activity of BNT162b2-elicited serum"},{"title3":"Neutralization of SARS-CoV-2 spike 69/70 deletion E484K and N501Y variants by BNT162b2 vaccine-elicited sera"},{"title3":"Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies"},{"title3":"Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera"},{"title3":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7"},{"title3":"SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera"},{"title3":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus"},{"title3":"Neutralizing activity of BNT162b2-elicited serum:preliminary report"},{"title3":"Tarke, A. et al. Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees. Preprint at bioRxiv10.1101/2021.02.27.433180 (2021)."},{"title3":"South African variant found in about 1% of all positive tests. MOHhttps://www.gov.il/en/departments/news/22022021-01 (2021)."},{"title3":"Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies"},{"title3":"Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med.10.1038/s41591-021-01377-8 (2021)."},{"title3":"Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study"},{"title3":"Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates"},{"title3":"Optimising the COVID-19 vaccination programme for maximum short-term impact. GOV.UKhttps://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement/optimising-the-covid-19-vaccination-programme-for-maximum-short-term-impact (2021)."},{"title3":"Abu-Raddad, L. J. et al. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. N. Engl. J. Med.10.1056/NEJMc2104974 (2021)."},{"title3":"Greaney, A. J. et al. Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies. Preprint at bioRxiv10.1101/2020.12.31.425021 (2021)."},{"title3":"Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants"},{"title3":"Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition"},{"title3":"Prospective mapping of viral mutations that escape antibodies used to treat COVID-19"},{"title3":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity"},{"title3":"Walker, A. S. et al. Increased infections, but not viral burden, with a new SARS-CoV-2 variant. Preprint at medRxiv10.1101/2021.01.13.21249721 (2021)."},{"title3":"Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine"},{"title3":"Petter, E. et al. Initial real world evidence for lower viral load of individuals who have been vaccinated by BNT162b2. Preprint at medRxiv10.1101/2021.02.08.21251329 (2021)."},{"title3":"COVID-19 Dashboard (Israeli Ministry of Health); https://datadashboard.health.gov.il/COVID-19/general (accessed 26 May 2021)"},{"title3":"Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR"},{"title3":"pTrimmer: an efficient tool to trim primers of multiplex deep sequencing data"},{"title3":"Drivers of within-host genetic diversity in acute infections of viruses"},{"title3":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs"},{"title3":"A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology"},{"title3":"Dudas, G. et al. Travel-driven emergence and spread of SARS-CoV-2 lineage B.1.620 with multiple VOC-like mutations and deletions in Europe. Preprint at medRxiv10.1101/2021.05.04.21256637 (2021)."},{"title3":"McKinney, W. Data structures for statistical computing in Python. In Proc. 9th Python in Science Conference (2010)."},{"title3":"Matplotlib: a 2D graphics environment"},{"title3":"Villanueva, R. A. M. &amp; Chen, Z. J. ggplot2: Elegant Graphics for Data Analysis (Taylor &amp; Francis, 2019)."},{"title3":"MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform"},{"title3":"Guindon, S. et al. in Bioinformatics for DNA Sequence Analysis (ed Posada, D.) 113-137 (Springer, 2009)."}]},{"title2":"Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State","References":[]},{"title2":"Hospitalised vaccinated patients during the second wave, update April '21","References":[]},{"title2":"Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK","References":[{"title3":"Coronavirus (COVID-19) in the UK"},{"title3":"COVID-19: admissions to Hospital - Update"},{"title3":"Declining death rate from COVID-19 in hospitals in England"},{"title3":"Doctors report big drop in hospital coronavirus deaths"},{"title3":"Deaths registered weekly in England and Wales, provisional: week ending 1 January 2021"},{"title3":"Lightening the viral load to lessen covid-19 severity"},{"title3":"Reports. ICNARC report on COVID-19 in critical care: England, Wales and Northern Ireland"},{"title3":"SICSAG report on COVID-19"},{"title3":"Dexamethasone in hospitalized patients with Covid-19:preliminary report"},{"title3":"Effect of Hydrocortisone on mortality and organ support in patients with severe COVID-19"},{"title3":"Open source clinical science for emerging infections"},{"title3":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study"},{"title3":"Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score"},{"title3":"COVID-19: government announces moving out contain phase into delay"},{"title3":"Extension of COVID-19 COPI notice"},{"title3":"Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients"},{"title3":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19. A meta-analysis"},{"title3":"Covid-19: England comes into line with rest of UK on recording deaths"},{"title3":"Imputation strategies for the estimation of natural direct and indirect effects"},{"title3":"Trends in COVID-19 risk-adjusted mortality rates"},{"title3":"Trends in intensive care for patients with COVID-19 in England, Wales and Northern Ireland"},{"title3":"Improving survival of critical care patients with coronavirus disease 2019 in England"},{"title3":"Coronavirus disease (COVID-19)"},{"title3":"The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects"},{"title3":"Shielding update"},{"title3":"Prime Minister's statement on coronavirus (COVID-19): 23 March 2020"},{"title3":"Slight reduction in SARS-CoV-2 exposure viral load due to masking results in a significant reduction in transmission with widespread implementation"},{"title3":"SARS-CoV-2 viral load predicts COVID-19 mortality"},{"title3":"Resilient health and care. Learning the lessons of COVID-19 in the English NHS"},{"title3":"Intensive care beds capacity"},{"title3":"A geotemporal survey of hospital bed saturation across England during the first wave of the COVID-19 pandemic"},{"title3":"Impact on mortality of prompt admission to critical care for deteriorating ward patients: an instrumental variable analysis using critical care bed strain"},{"title3":"The association between hospital overcrowding and mortality among patients admitted via Western Australian emergency departments"},{"title3":"Critical care work during COVID-19: a sociological analysis of staff experiences"},{"title3":"Long-term survival of elderly patients after intensive care unit admission for acute respiratory infection: a population-based, propensity score-matched cohort study"},{"title3":"Effect of systematic intensive care unit triage on long-term mortality among critically ill elderly patients in France: a randomized clinical trial"},{"title3":"What realistic medicine is: and what it isn't"}]},{"title2":"Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study","References":[{"title3":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?"},{"title3":"Coronavirus resource center"},{"title3":"Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities"},{"title3":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019: COVID-NET, 14 States, March 1-30, 2020"},{"title3":"COVID-19: the case for health-care worker screening to prevent hospital transmission"},{"title3":"Characteristics of health care personnel with COVID-19: United States, February 12-April 9, 2020"},{"title3":"COVID-19 in Italy: momentous decisions and many uncertainties"},{"title3":"Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff"},{"title3":"Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic"},{"title3":"COVID-19 personal protective equipment (PPE): 5:summary of PPE recommendations for health and social care workers"},{"title3":"Assessment of N95 respirator decontamination and re-use for SARS-CoV-2"},{"title3":"Decontamination and reuse of N95 respirators with hydrogen peroxide vapor to address worldwide personal protective equipment shortages during the SARS-CoV-2 (COVID-19) pandemic"},{"title3":"Sourcing personal protective equipment during the COVID-19 pandemic"},{"title3":"COVID-19: protecting health-care workers"},{"title3":"Rapid implementation of mobile technology for real-time epidemiology of COVID-19"},{"title3":"Real-time tracking of self-reported symptoms to predict potential COVID-19"},{"title3":"Epidemiology of and risk factors for coronavirus infection in health care workers: a living rapid review"},{"title3":"Fifth of frontline doctors complain of unusable coronavirus PPE"},{"title3":"Evaluating the national PPE guidance for NHS healthcare workers during the COVID-19 pandemic"},{"title3":"Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity"},{"title3":"COVID-19: PCR screening of asymptomatic health-care workers at London hospital"},{"title3":"Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: a cross-sectional study"},{"title3":"SARS: health care work can be hazardous to health"},{"title3":"Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)"},{"title3":"SARS transmission among hospital workers in Hong Kong"},{"title3":"Pandemic (H1N1) 2009 risk for frontline health care workers"},{"title3":"Risk factors for pandemic (H1N1) 2009 virus seroconversion among hospital staff, Singapore"},{"title3":"Putting the public back in public health: surveying symptoms of Covid-19"},{"title3":"The COronavirus Pandemic Epidemiology (COPE) Consortium: a call to action"},{"title3":"Mobile fact sheet"}]},{"title2":"Geo-social gradients in predicted COVID-19 prevalence in Great Britain: results from 1 960 242 users of the COVID-19 Symptoms Study app","References":[{"title3":"COVID-19 attack rate increases with City size"},{"title3":"Health equity in England: the Marmot review 10 years on"},{"title3":"Influenza-Associated hospitalisation, vaccine uptake and socioeconomic deprivation in an English City region: an ecological study"},{"title3":"Pandemic influenza planning in the United States from a health disparities perspective"},{"title3":"Rapid implementation of mobile technology for real-time epidemiology of COVID-19"},{"title3":"Real-Time tracking of self-reported symptoms to predict potential COVID-19"},{"title3":"Use of local Moran's I and GIS to identify pollution hotspots of Pb in urban soils of Galway, Ireland"},{"title3":"Do spatial effects really matter in regression analysis? Papers - Regional Science Association"},{"title3":"Collider bias undermines our understanding of COVID-19 disease risk and severity"},{"title3":"Is ethnicity linked to incidence or outcomes of covid-19?"}]},{"title2":"Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study","References":[{"title3":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges"},{"title3":"Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Defining the epidemiology of Covid-19:studies needed"},{"title3":"The representativeness of sentinel practice networks"},{"title3":"Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile"},{"title3":"RCGP Research and Surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions"},{"title3":"Weekly returns service of the Royal College of General Practitioners"},{"title3":"End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19"},{"title3":"Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17"},{"title3":"Ten lessons for the next influenza pandemic:an English perspective: a personal reflection based on community surveillance data"},{"title3":"Serological surveillance of influenza in an English sentinel network: pilot study protocol"},{"title3":"Emergence of a novel coronavirus (COVID-19): protocol for extending surveillance used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England"},{"title3":"Household presentation of acute gastroenteritis in a primary care sentinel network: retrospective database studies"},{"title3":"Conurbation, urban, and rural living as determinants of allergies and infectious diseases: Royal College of General Practitioners Research and Surveillance Centre Annual Report 2016-2017"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"Guidance and standard operating procedure: COVID-19 virus testing in NHS laboratories"},{"title3":"COVID-19 Surveillance Ontology"},{"title3":"Coronavirus (COVID-19): notice under reg 3(4) of the Health Service Control of Patient Information Regulations 2002:general"},{"title3":"Defining research table"},{"title3":"Ethnicity recording in primary care computerised medical record systems: an ontological approach"},{"title3":"The English Index of Multiple Deprivation (IMD) 2015:Guidance"},{"title3":"Multivariate imputation by chained equations in R"},{"title3":"Construction and assessment of prediction rules for binary outcome in the presence of missing predictor data using multiple imputation and cross-validation: methodological approach and data-based evaluation"},{"title3":"KS201EW: ethnic group"},{"title3":"Census geography: 2001 output areas"},{"title3":"COVID-19: what has been learned and to be learned about the novel coronavirus disease"},{"title3":"Epidemiology of 2019 novel coronavirus in Jiangsu Province, China after wartime control measures: a population-level retrospective study"},{"title3":"Investigating regional variation of respiratory infections in a general practice syndromic surveillance system"},{"title3":"Coronavirus (COVID-19) roundup"},{"title3":"Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study"},{"title3":"Ethnicity and COVID-19: an urgent public health research priority"},{"title3":"ICNARC report on COVID-19 in critical care"},{"title3":"Population of England and Wales"},{"title3":"Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis"},{"title3":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis"},{"title3":"CKD and the risk of acute, community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using electronic health records"},{"title3":"Short- and long-term outcomes after incident pneumonia in adults with chronic kidney disease: a time-dependent analysis from the Stockholm CREAtinine Measurement project"},{"title3":"Obesity and respiratory diseases"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"COVID-19 and smoking: a systematic review of the evidence"},{"title3":"Tobacco and the lung cancer epidemic in China"},{"title3":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019:United States, February 12-March 28, 2020"},{"title3":"Smoking may increase the risk of influenza hospitalization and reduce influenza vaccine effectiveness in the elderly"},{"title3":"Illustrating bias due to conditioning on a collider"},{"title3":"Nicotine and the renin-angiotensin system"},{"title3":"ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19"},{"title3":"Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS-CoV-2"},{"title3":"Accounting for missing data in statistical analyses: multiple imputation is not always the answer"},{"title3":"Self-sampling for community respiratory illness: a new tool for national virological surveillance"}]},{"title2":"The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Frailty predicts mortality in all emergency surgical admissions regardless of age. An observational study"},{"title3":"Ventilator allocation guidelines"},{"title3":"NICE updates rapid COVID-19 guideline on critical care"},{"title3":"A global clinical measure of fitness and frailty in elderly people"},{"title3":"Frailty consensus: a call to action"},{"title3":"Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants"},{"title3":"Clinical frailty adds to acute illness severity in predicting mortality in hospitalized older adults: an observational study"},{"title3":"Frailty exists in younger adults admitted as surgical emergency leading to adverse outcomes"},{"title3":"Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study"},{"title3":"How the frailty index may support the allocation of health care resources: an example from the INCUR study"},{"title3":"The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis"},{"title3":"Lightning learning: clinical frailty scale"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Frailty in older patients undergoing emergency laparotomy: results from the UK observational Emergency Laparotomy and Frailty (ELF) study"},{"title3":"Parametric frailty and shared frailty survival models"},{"title3":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study"},{"title3":"Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials"},{"title3":"Decision-making in COVID-19 and frailty"},{"title3":"External validation of the electronic Frailty Index using the population of Wales within the secure anonymised information linkage databank"}]},{"title2":"Factors associated with COVID-19-related death using OpenSAFELY","References":[{"title3":"Clinical determinants for fatality of 44,672 patients with COVID-19"},{"title3":"Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Is ethnicity linked to incidence or outcomes of covid-19?"},{"title3":"Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?"},{"title3":"COVID-19 in Great Britain: epidemiological and clinical characteristics of the first few hundred (FF100) cases: a descriptive study"},{"title3":"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years"},{"title3":"Impact Of Electronic Health Record Interface Design On Unsafe Prescribing Of Ciclosporin, Tacrolimus and Diltiazem: A Cohort Study In English NHS Primary Care"},{"title3":"Quality of Co-Prescribing NSAID and Gastroprotective Medications for Elders in The Netherlands and Its Association with the Electronic Medical Record"},{"title3":"Ghost branded generics: Why does the cost of generic atorvastatin vary?"},{"title3":"Completeness and usability of ethnicity data in UK-based primary care and hospital databases"},{"title3":"Closing the gap in a generation: health equity through action on the social determinants of health"},{"title3":"Development and validation of an electronic frailty index using routine primary care electronic health record data"},{"title3":"Estimating primary care attendance rates for fever in infants after meningococcal B vaccination in England using national syndromic surveillance data"},{"title3":"The relationship between time since registration and measured incidence rates in the General Practice Research Database"},{"title3":"A New Equation to Estimate Glomerular Filtration Rate"},{"title3":"What is the dm+d? The NHS Dictionary of Medicines and Devices"},{"title3":"Validation of asthma recording in the Clinical Practice Research Datalink (CPRD)"},{"title3":"OpenSAFELY Codelists: Asthma Oral Prednisolone Medication"},{"title3":"Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis"},{"title3":"OpenSAFELY Codelists: Permanent Immunosuppresion"},{"title3":"OpenSAFELY Codelists: Temporary Immunosuppresion"},{"title3":"Clinical Code List-Psoriasis-Read Codes"},{"title3":"Clinical code list - SLE codes"},{"title3":"Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England"},{"title3":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases"},{"title3":"Population-calibrated multiple imputation for a binary/categorical covariate in categorical regression models"}]},{"title2":"Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination","References":[{"title3":"Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy"},{"title3":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting"},{"title3":"SARS-CoV-2 infection after vaccination in health care workers in California"},{"title3":"Early evidence of the effect of SARS-CoV-2 vaccine at one medical center"},{"title3":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine"},{"title3":"Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants"},{"title3":"VA. https://www.va.gov/health/aboutvha.asp accessed April 7, 2021. 2021."}]},{"title2":"Symptom clusters in COVID-19: a potential clinical prediction tool from the COVID Symptom Study app","References":[{"title3":"Fair allocation of scarce medical resources in the time of Covid-19"},{"title3":"Intensive care management of coronavirus disease 2019 (COVID-19): Challenges and recommendations"},{"title3":"Rapid implementation of mobile technology for real-time epidemiology of COVID-19"},{"title3":"Real-time tracking of self-reported symptoms to predict potential COVID-19"},{"title3":"COVID-19 and gastrointestinal symptoms:A case report"},{"title3":"Atypical presentation of COVID-19 in a frail older person"},{"title3":"Prolonged confusional state as first manifestation of COVID-19"},{"title3":"Multivariate time series clustering based on common principal component analysis"},{"title3":"PRISMA-7: A case-finding tool to identify older adults with moderate to severe disabilities"},{"title3":"Index for rating diagnostic tests"},{"title3":"Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19"},{"title3":"Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection"},{"title3":"Identification of pathophysiological patterns for triage and respiratory support in COVID-19"},{"title3":"Rational application of respiratory support technique in patients with COVID-19 pneumonia"}]},{"title2":"Attributes and predictors of long COVID","References":[]},{"title2":"Real-time tracking of self-reported symptoms to predict potential COVID-19","References":[{"title3":"Coronavirus: rolling out community testing for COVID-19 in the NHS"},{"title3":"A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys"},{"title3":"Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?"},{"title3":"Sixty seconds on... anosmia"},{"title3":"Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia"},{"title3":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes"},{"title3":"Sudden and complete olfactory loss function as a possible symptom of COVID-19"},{"title3":"Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection"},{"title3":"Rapid implementation of mobile technology for real-time epidemiology of COVID-19"},{"title3":"Coronavirus: are loss of smell and taste key symptoms?"},{"title3":"Consequences of undetected olfactory loss for human chemosensory communication and well-being"},{"title3":"Computationally efficient confidence intervals for cross-validated area under the ROC curve estimates"}]},{"title2":"A Euclidean distance-based matching procedure for nonrandomized comparison studies","References":[]},{"title2":"PRISMA-7: a case-finding tool to identify older adults with moderate to severe disabilities","References":[]},{"title2":"Probable delirium is a presenting symptom of COVID-19 in frail, older adults: a cohort study of 322 hospitalised and 535 community-based older adults","References":[{"title3":"Comorbidity and its impact on 1590 patients with Covid-19 in China: a Nationwide analysis"},{"title3":"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study"},{"title3":"Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy"},{"title3":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) : United States, February 12-March 16, 2020"},{"title3":"Factors associated with COVID-19-related death using OpenSAFELY"},{"title3":"Age and immunity: what is 'immunosenescence'?"},{"title3":"Frailty and sarcopenia: the potential role of an aged immune system"},{"title3":"Elderly patients with an atypical presentation of illness in the emergency department"},{"title3":"COVID-19 in older adults: key points for emergency department providers"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients"},{"title3":"A comparative-descriptive analysis of clinical characteristics in 2019-coronavirus-infected children and adults"},{"title3":"Atypical presentation of COVID-19 in a frail older person"},{"title3":"Detecting SARS-CoV-2 at point of care: preliminary data comparing loop-mediated isothermal amplification (LAMP) to PCR"},{"title3":"Frailty in elderly people"},{"title3":"Frailty in older adults: evidence for a phenotype"},{"title3":"COVID-19 rapid guideline: critical care in adults"},{"title3":"The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study"},{"title3":"Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people"},{"title3":"Delirium: a missing piece in the COVID-19 pandemic puzzle"},{"title3":"Frailty and COVID-19: a systematic scoping review"},{"title3":"The Geriatric Medicine Research Collaborative (GEMRC): Inception and Dissemination of a New National Trainee-led Research Collaborative Trainee-led Research Collaborative"},{"title3":"A global clinical measure of fitness and frailty in elderly people"},{"title3":"Revis"},{"title3":"PRISMA-7: a case-finding tool to identify older adults with moderate to severe disabilities"},{"title3":"Fit for practice"},{"title3":"Comparison of frailty screening instruments in the emergency department"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"}]},{"title2":"Predictive validity of PRISMA-7 as a screening instrument for frailty in a hospital setting","References":[{"title3":"Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project"},{"title3":"Frailty in elderly people"},{"title3":"Unstable disability and the fluctuations of frailty"},{"title3":"Three decades of comprehensive geriatric assessment: evidence coming from different healthcare settings and specific clinical conditions"},{"title3":"Fit for frailty, consensus best practice guideline for the care of older people living with frailty in the community and outpatient settings"},{"title3":"Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review"},{"title3":"PRISMA: a new model of integrated service delivery for the frail older people in Canada"},{"title3":"PRISMA: a new model of integrated service delivery for the frail older people in Canada"},{"title3":"Best practice guidelines for the management of frailty: a British geriatrics Society, age UK and Royal College of general practitioners report"},{"title3":"Fit for frailty"},{"title3":"Comparison of frailty screening instruments in the emergency department"},{"title3":"Screening for older inpatients at risk for long length of stay: which clinical tool to use?"},{"title3":"Identifying frailty in the emergency Department-feasibility study"},{"title3":"Identifying the loss of functional independence of older people residing in the community: validation of the PRISMA-7 instrument in Brazil"},{"title3":"Identification of frailty in primary care: feasibility and acceptability of recommended case finding tools within a primary care integrated seniors' program"},{"title3":"Frailty and mortality: an 18-year follow-up study among Finnish community-dwelling older people"},{"title3":"The validation of the PRISMA-7 questionnaire in community-dwelling elderly people living in Antalya, Turkey"},{"title3":"German translation, cross-cultural adaptation and diagnostic test accuracy of three frailty screening tools : PRISMA-7, FRAIL scale and Groningen Frailty Indicator"},{"title3":"[Cross-cultural adaptation of the PRISMA-7 instrument for use in Brazil: evaluation of conceptual, item, and semantic equivalences]"},{"title3":"The Danish national patient register"},{"title3":"The Danish National health service register"},{"title3":"The Danish register of causes of death"},{"title3":"Registration of acute medical hospital admissions in the Danish national patient registry: a validation study"},{"title3":"The Danish civil registration system as a tool in epidemiology"},{"title3":"Dream"},{"title3":"Frailty in older adults: evidence for a phenotype"},{"title3":"Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries"},{"title3":"Frailty as a predictor of adverse outcomes in hospitalized older adults: a systematic review and meta-analysis"},{"title3":"Frailty and the prediction of negative health outcomes: a meta-analysis"},{"title3":"Frailty as a predictor of mortality and hospital services use in older adults: a cluster analysis in a cohort study"}]},{"title2":"Ministry of Housing, Communities &amp; Local Government. National statistics. English indices of deprivation 2019","References":[]},{"title2":"Lifestyle-based prediction model for the prevention of CVD: the Healthy Heart Score","References":[{"title3":"Heart disease and stroke statistics:2013 update: a report from the American Heart Association"},{"title3":"Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study"},{"title3":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project"},{"title3":"Prediction of coronary heart disease using risk factor categories"},{"title3":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study"},{"title3":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score"},{"title3":"Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)"},{"title3":"Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Munster (PROCAM) study"},{"title3":"2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines"},{"title3":"2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines"},{"title3":"Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006"},{"title3":"CVD screening in low-risk, asymptomatic adults: clinical trials needed"},{"title3":"Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women"},{"title3":"Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality"},{"title3":"Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults"},{"title3":"Lifetime risks of cardiovascular disease"},{"title3":"Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age"},{"title3":"Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial"},{"title3":"Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT)"},{"title3":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin"},{"title3":"Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: the Coronary Artery Risk Development in (Young) Adults (CARDIA) study"},{"title3":"Healthy lifestyle and the risk of stroke in women"},{"title3":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study"},{"title3":"Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project"},{"title3":"Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes"},{"title3":"A prospective study of parental history of myocardial infarction and coronary artery disease in men"},{"title3":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines"},{"title3":"Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association"},{"title3":"Myocardial infarction redefined:a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction"},{"title3":"The National Survey of Stroke. Clinical findings"},{"title3":"Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals"},{"title3":"Validity of self-reported waist and hip circumferences in men and women"},{"title3":"Reproducibility and validity of a expanded self-administered semiquantitative food frequency questionnaire among male health professionals"},{"title3":"The assessment of alcohol consumption by a simple self-administered questionnaire"},{"title3":"A cautionary note on the use of the Gronnesby and Borgan goodness-of-fit test for the Cox proportional hazards model"},{"title3":"Evaluation of the performance of survival analysis models: discrimination and calibration measures"},{"title3":"Fruit and vegetable consumption and stroke: meta-analysis of cohort studies"},{"title3":"Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies"},{"title3":"Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals"},{"title3":"Sweetened beverage consumption and risk of coronary heart disease in women"},{"title3":"Soda consumption and the risk of stroke in men and women"},{"title3":"Dietary protein sources and the risk of stroke in men and women"},{"title3":"Major dietary protein sources and risk of coronary heart disease in women"},{"title3":"National study of physician awareness and adherence to cardiovascular disease prevention guidelines"},{"title3":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond"},{"title3":"Status of cardiovascular health in US adolescents: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2005-2010"},{"title3":"Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys"},{"title3":"My life check"},{"title3":"Your disease risk"},{"title3":"Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies"},{"title3":"Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies"},{"title3":"Relationship of sedentary behavior and physical activity to incident cardiovascular disease: results from the Women's Health Initiative"},{"title3":"Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies"},{"title3":"Trans fatty acids and cardiovascular disease"},{"title3":"Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association"},{"title3":"Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association"}]},{"title2":"Symptoms of COVID-19","References":[]},{"title2":"Accessible data curation and analytics for international-scale citizen science datasets","References":[{"title3":"A new dawn for citizen science"},{"title3":"The future of citizen science: emerging technologies and shifting paradigms"},{"title3":"An analysis of citizen science based research: usage and publication patterns"},{"title3":"Opinion: Toward an international definition of citizen science"},{"title3":"Rapid implementation of mobile technology for real-time epidemiology of covid-19"},{"title3":"Practices of research data curation in institutional repositories: A qualitative view from repository staff"},{"title3":"The numpy array: a structure for efficient numerical computation"},{"title3":"Array programming with numpy"},{"title3":"Wes McKinney. Data Structures for Statistical Computing in Python. In Stefan van der Walt &amp; Jarrod Millman (eds.) Proceedings of the 9th Python in Science Conference, 56-61 (2010)."},{"title3":"Sql databases v. nosql databases"},{"title3":"Seltzer, M. I. &amp; Olson, M. A. Challenges in embedded database system administration. In Proceedings of the Workshop on Embedded Systems on Workshop on Embedded Systems, WOES'99, 11 (USENIX Association, USA, 1999)."},{"title3":"Apache spark: A unified engine for big data processing"},{"title3":"Vaex: big data exploration in the era of gaia"},{"title3":"Matplotlib: A 2D graphics environment"},{"title3":"Kluyver, T. et al. Jupyter notebooks - a publishing format for reproducible computational workflows. In Loizides, F. &amp; Schmidt, B. (eds.) Positioning and Power in Academic Publishing: Players, Agents and Agendas, 87-90 (2016)."},{"title3":"RAPIDS Development Team. RAPIDS: Collection of Libraries for End to End GPU Data Science (2018)."},{"title3":"Ni Lochlainn, M. et al. Key predictors of attending hospital with covid19: An association study from the covid symptom tracker app in 2,618,948 individuals. medRxiv (2020)."},{"title3":"Costeira, R. et al. Estrogen and covid-19 symptoms: associations in women from the covid symptom study. medRxiv (2020)."},{"title3":"Bowyer, R. et al. Geo-social gradients in predicted covid-19 prevalence and severity in great britain: results from 2,266,235 users of the covid-19 symptoms tracker app. medRxiv (2020)."},{"title3":"Bataille, V. et al. Diagnostic value of skin manifestation of sars-cov-2 infection. medRxiv (2020)."},{"title3":"Sudre, C. H. et al. Symptom clusters in covid-19: A potential clinical prediction tool from the covid symptom study app. Science Advances7 (2021)."},{"title3":"Effects of environmental factors on severity and mortality of covid-19"},{"title3":"Detecting covid-19 infection hotspots in england using large-scale self-reported data from a mobile application: a prospective, observational study"},{"title3":"Hopkinson, N. S. et al. Current smoking and covid-19 risk: results from a population symptom app in over 2.4 million people. Thorax (2021)."},{"title3":"C-store: A column-oriented dbms"},{"title3":"Institute, A. N. S. IEEE standard for information technology: Portable Operating System Interface (POSIX): part 2, shell and utilities (IEEE Computer Society Press, 1993)."},{"title3":"Pezoa, F., Reutter, J. L., Suarez, F., Ugarte, M. &amp; Vrgoc, D. Foundations of json schema. In Proceedings of the 25th International Conference on World Wide Web, 263-273 (International World Wide Web Conferences Steering Committee, 2016)."},{"title3":"Delorey, D. P., Knutson, C. D. &amp; Chun, S. Do programming languages affect productivity? a case study using data from open source projects. In First International Workshop on Emerging Trends in FLOSS Research and Development (FLOSS'07: ICSE Workshops 2007), 8-8 (2007)."},{"title3":"Lam, S. K., Pitrou, A. &amp; Seibert, S. Numba: A llvm-based python jit compiler. In Proceedings of the Second Workshop on the LLVM Compiler Infrastructure in HPC, LLVM '15 (Association for Computing Machinery, New York, NY, USA, 2015)."},{"title3":"Real-time tracking of self-reported symptoms to predict potential covid-19"},{"title3":"Risk of covid-19 among front-line health-care workers and the general community: a prospective cohort study"},{"title3":"Zazzara, M. B. et al. Delirium is a presenting symptom of covid-19 in frail, older adults: a cohort study of 322 hospitalised and 535 community-based older adults. medRxiv (2020)."}]},{"title2":"Inverse probability weighting","References":[]},{"title2":"Spike-antibody waning after second dose of BNT162b2 or ChAdOx1","References":[{"title3":"Association between mRNA vaccination and COVID-19 hospitalization and disease severity"},{"title3":"Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study"},{"title3":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study"},{"title3":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression"},{"title3":"Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study"},{"title3":"Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar"},{"title3":"SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort"},{"title3":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion"},{"title3":"Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic"},{"title3":"COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less immunity against omicron"},{"title3":"Interim recommendations for an extended primary series with an additional vaccine dose for COVID-19 vaccination in immunocompromised persons [Internet]. [cited 2023 Mar 15]; Available from: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-vaccines-SAGE_recommendation-immunocompromised-persons."},{"title3":"Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19 [Internet]. [cited 2023 Mar 15]; Available from: https://www.who.int/news/item/17-05-2022-interim-statement-on-the-use-of-additional-booster-doses-of-emergency-use-listed-mrna-vaccines-against-covid-19."},{"title3":"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial"},{"title3":"Homologous and heterologous Covid-19 booster vaccinations"},{"title3":"Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study"},{"title3":"Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated vaccine"},{"title3":"Effectiveness of BBV152, Covaxin and AZD1222, Covishield vaccines against severe COVID-19 and B.1.617.2, Delta variant in India, a multi-centric hospital-based case-control study"},{"title3":"Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses"},{"title3":"SARS-CoV-2 reinfection rate and estimated effectiveness of the inactivated whole virion vaccine BBV152 against reinfection among health care workers in New Delhi"},{"title3":"GuidelinesforCOVID19VaccinationofChildrenbetween15to18yearsandPrecautionDosetoHCWsFLWs&amp;60populationwithcomorbidities.pdf [Internet]. [cited 2023 Feb 25]. - Google Search [Internet]. [cited 2023 Mar 16];Available from: https://www.google.com/search?q=GuidelinesforCOVID19VaccinationofChildrenbetween15to18yearsandPrecautionDosetoHCWsFLWs %2660populationwithcomorbidities.pdf+ %5BInternet %5D.+ %5Bcited+2023+Feb+25 %5D.&amp;rlz=1C5CHFA_enIN905IN908&amp;oq=GuidelinesforCOVID19VaccinationofChildrenbetween15to18yearsandPrecautionDosetoHCWsFLWs %2660populationwithcomorbidities.pdf+ %5BInternet %5D.+ %5Bcited+2023+Feb+25 %5D.&amp;aqs=chrome..69i57j69i59.346j0j7&amp;sourceid=chrome&amp;ie=UTF-8."},{"title3":"Rose W, Raju R, Babji S, George A, Madhavan R, Leander Xavier JV, et al. Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD ) and BBV152 (COVAXIN ): a non-inferiority phase 4, participant and observer-blinded, randomised study. Lancet Reg Health Southeast Asia 2023;100141."},{"title3":"GeurtsvanKessel CH, Geers D, Schmitz KS, Mykytyn AZ, Lamers MM, Bogers S, et al. Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients. Sci Immunol:eabo2202."},{"title3":"Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants"},{"title3":"Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM ) and BBV-152 (CovaxinTM ) among health care workers in India: the final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study"},{"title3":"Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study"},{"title3":"Low protease activity in B cell follicles promotes retention of intact antigens after immunization"},{"title3":"Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2"},{"title3":"Influence of the microbiota on vaccine effectiveness"},{"title3":"CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity"},{"title3":"CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses"},{"title3":"Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination"},{"title3":"AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2"},{"title3":"Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination"}]},{"title2":"Coronavirus (COVID-19): getting tested","References":[]},{"title2":"Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults","References":[{"title3":"The effect of ageing of the immune system on vaccination responses"},{"title3":"Find drugs that delay many diseases of old age"},{"title3":"The quest to slow ageing through drug discovery"},{"title3":"mTORC inhibitors as broad-spectrum therapeutics for age-related diseases"},{"title3":"TORC1 inhibition enhances immune function and reduces infections in the elderly"},{"title3":"LB2. TORC1 inhibition with RTB101 as a potential pan-antiviral immunotherapy to decrease the incidence of respiratory tract infections due to multiple respiratory viruses in older adults"},{"title3":"Simvastatin improves neutrophil function and clinical outcomes in pneumonia. A pilot randomized controlled clinical trial"},{"title3":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19"},{"title3":"Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study"},{"title3":"Observational study of metformin and risk of mortality in patients hospitalized with Covid-19"}]},{"title2":"Aging and the immune system: the impact of immunosenescence on viral infection, immunity and vaccine immunogenicity","References":[{"title3":"The hallmarks of aging"},{"title3":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases"},{"title3":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases"},{"title3":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo "},{"title3":"Cellular senescence: when bad things happen to good cells"},{"title3":"Understanding immunosenescence to improve responses to vaccines"},{"title3":"Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals"},{"title3":"B-cell diversity decreases in old age and is correlated with poor health status"},{"title3":"Age-associated defect in human TLR-1/2 function"},{"title3":"Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response"},{"title3":"Paradoxical changes in innate immunity in aging: recent progress and new directions"},{"title3":"Cutting edge: impaired Toll-like receptor expression and function in aging"},{"title3":"Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly"},{"title3":"Direct regulation of TLR5 expression by caveolin-1"},{"title3":"Damage-associated molecular patterns in inflammatory diseases"},{"title3":"NLRP3 inflammasome activation in inflammaging"},{"title3":"Critical role of NLRP3-caspase-1 pathway in age-dependent isoflurane-induced microglial inflammatory response and cognitive impairment"},{"title3":"NLRP3-inflammasomes are triggered by age-related hearing loss in the inner ear of mice"},{"title3":"NLRP3 inflammasome activation in aged macrophages is diminished during Streptococcus pneumoniae infection"},{"title3":"Impaired NLRP3 inflammasome function in elderly mice during influenza infection is rescued by treatment with nigericin"},{"title3":"Canonical NLRP3 inflammasome links systemic low-grade inflammation to functional decline in aging"},{"title3":"Global analyses revealed age-related alterations in innate immune responses after stimulation of pathogen recognition receptors"},{"title3":"Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults"},{"title3":"Human monocyte subsets are transcriptionally and functionally altered in aging in response to pattern recognition receptor agonists"},{"title3":"Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function"},{"title3":"Dysregulation of human Toll-like receptor function in aging"},{"title3":"The unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in macrophage function"},{"title3":"IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice"},{"title3":"Metabolic alterations in aging macrophages: ingredients for inflammaging?"},{"title3":"Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood"},{"title3":"Peripheral blood dendritic cells and monocytes are differently regulated in the elderly"},{"title3":"Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing"},{"title3":"Effect of aging on epidermal dendritic cell populations in C57BL/6J mice"},{"title3":"The effect of aging on the density and distribution of oral mucosal Langerhans cells"},{"title3":"Surface markers and transendothelial migration of dendritic cells from elderly subjects"},{"title3":"Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA"},{"title3":"Biology of dendritic cells in aging"},{"title3":"Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway"},{"title3":"Current understanding in neutrophil differentiation and heterogeneity"},{"title3":"Effect of age on human neutrophil function"},{"title3":"Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence"},{"title3":"Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis"},{"title3":"Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans"},{"title3":"Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging: cross-sectional and longitudinal studies"},{"title3":"Innate immune dysfunctions in aged mice facilitate the systemic dissemination of methicillin-resistant S. aureus"},{"title3":"Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals"},{"title3":"Age- and tissue-specific differences in human germinal center B cell selection revealed by analysis of IgVH gene hypermutation and lineage trees"},{"title3":"A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation"},{"title3":"B lymphopoiesis is active throughout human life, but there are developmental age-related changes"},{"title3":"Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells"},{"title3":"Age-related changes in the capability of the bone marrow to generate B cells"},{"title3":"The twilight of immunity: emerging concepts in aging of the immune system"},{"title3":"MicroRNAs miR-155 and miR-16 Decrease AID and E47 in B Cells from Elderly Individuals"},{"title3":"Decreased E47 in senescent B cell precursors is stage specific and regulated posttranslationally by protein turnover"},{"title3":"Reduced Ig class switch in aged mice correlates with decreased E47 and activation-induced cytidine deaminase"},{"title3":"Senescent B cells in aging and age-related diseases: their role in the regulation of antibody responses"},{"title3":"Repertoire diversity of antibody response to bacterial antigens in aged mice. IV. Study of VH and VL gene utilization in splenic antibody foci by in situ hybridization"},{"title3":"Increased VH 11 and VH Q52 gene use by splenic B cells in old mice associated with oligoclonal expansions of CD5 + B cells"},{"title3":"Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice"},{"title3":"Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires"},{"title3":"Epigenetics of T cell aging"},{"title3":"Impact of immune-metabolic interactions on age-related thymic demise and T cell senescence"},{"title3":"Human T cell immunosenescence and inflammation in aging"},{"title3":"Age-associated alterations in inducible gene transcription in human CD4+ T lymphocytes"},{"title3":"Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling"},{"title3":"Normal ageing is associated with an increase in Th2 cells, MCP-1 (CCL1) and RANTES (CCL5), with differences in sCD40L and PDGF-AA between sexes"},{"title3":"Update on regulation and effector functions of Th17 cells"},{"title3":"The Th17/Treg balance is disturbed during aging"},{"title3":"A CD153+CD4+ T follicular cell population with cell-senescence features plays a crucial role in lupus pathogenesis via osteopontin production"},{"title3":"The impact of senescence-associated T cells on immunosenescence and age-related disorders"},{"title3":"Cytomegalovirus infection and memory T cell inflation"},{"title3":"Evolution of diverse antiviral CD8+ T cell populations after murine cytomegalovirus infection"},{"title3":"Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells"},{"title3":"Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection"},{"title3":"Senescence of T lymphocytes: implications for enhancing human immunity"},{"title3":"T cell subset-specific susceptibility to aging"},{"title3":"Age-associated up-regulation of a negative co-stimulatory receptor PD-1 in mouse CD4+ T cells"},{"title3":"CTLA-4 upregulation during aging"},{"title3":"Characterization of age-associated exhausted CD8+ T cells defined by increased expression of Tim-3 and PD-1"},{"title3":"The mechanism of action of MF59 - an innately attractive adjuvant formulation"},{"title3":"Safety of AS03-adjuvanted influenza vaccines: a review of the evidence"},{"title3":"Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults &gt;=50 years of age"},{"title3":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older"},{"title3":"Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008"},{"title3":"The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly"},{"title3":"Influenza virus vaccination elicits poorly adapted B cell responses in elderly individuals"},{"title3":"Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans"},{"title3":"Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors"},{"title3":"Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging"},{"title3":"Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine"},{"title3":"Enhanced viral replication by cellular replicative senescence"},{"title3":"Insights into the role of immunosenescence during varicella zoster virus infection (shingles) in the aging cell model"},{"title3":"Usefulness of inflammatory markers for the prediction of postherpetic neuralgia in patients with acute herpes zoster"},{"title3":"Decreased absolute numbers of CD3+ T cells and CD8+ T cells during aging in herpes zoster patients"},{"title3":"Serum C-reactive protein and congestive heart failure as significant predictors of herpes zoster vaccine response in elderly nursing home residents"},{"title3":"Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans"},{"title3":"Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: a systematic review"},{"title3":"The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire"},{"title3":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects"},{"title3":"Aging, cytomegalovirus (CMV) and influenza vaccine responses"},{"title3":"Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination"},{"title3":"Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly"},{"title3":"Omics technologies and the study of human ageing"},{"title3":"The role of the immune system in metabolic health and disease"},{"title3":"Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates"},{"title3":"Age-dependent cell trafficking defects in draining lymph nodes impair adaptive immunity and control of west nile virus infection"},{"title3":"Defective TFH cell function and increased TFR cells contribute to defective antibody production in aging"},{"title3":"Exosome secretion: molecular mechanisms and roles in immune responses"},{"title3":"Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2"},{"title3":"Aging enhances release of exosomal cytokine mRNAs by Abeta1-42-stimulated macrophages"},{"title3":"Revolutionizing immunology with single-cell RNA sequencing"},{"title3":"Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment"}]},{"title2":"COVID-19 rapid guideline: managing COVID-19","References":[]},{"title2":"Identifying frailty","References":[]},{"title2":"SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic","References":[{"title3":"Office for National Statistics. Comparisons of All-cause Mortality between European Countries and Regions: January to June 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/comparisonsofallcausemortalitybetweeneuropeancountriesandregions/januarytojune2020 (2020)."},{"title3":"Leon, D. A., Jarvis, C. I., Johnson, A. M., Smeeth, L. &amp; Shkolnikov, V. M. What can trends in hospital deaths from COVID-19 tell us about the progress and peak of the pandemic? An analysis of death counts from England announced up to 25 April 2020. medRxiv10.1101/2020.04.21.20073049 (2020)."},{"title3":"Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study"},{"title3":"Williamson, E. J. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature10.1038/s41586-020-2521-4 (2020)."},{"title3":"Public Health England. Disparities in the Risk and Outcomes of COVID-19. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/892085/disparities_review.pdf (2020)."},{"title3":"Black, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data"},{"title3":"Racial health disparities and Covid-19:caution and context"},{"title3":"Hospitalization and mortality among Black patients and White patients with Covid-19"},{"title3":"Ethnicity and covid-19"},{"title3":"Antibody responses to SARS-CoV-2 in patients with COVID-19"},{"title3":"Bobrovitz, N. et al. Lessons from a rapid systematic review of early SARS-CoV-2 serosurveys. medRxiv10.1101/2020.05.10.20097451 (2020)."},{"title3":"Liu, T. et al. Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan:implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2. medRxiv, 10.1101/2020.06.13.20130252 (2020)."},{"title3":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study"},{"title3":"Pollan, M. et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet Lond. Engl. 10.1016/S0140-6736(20)31483-5 (2020)."},{"title3":"Adams, E. R. et al. Antibody testing for COVID-19: a report from the National COVID Scientific Advisory Panel. medRxiv10.1101/2020.04.15.20066407 (2020)."},{"title3":"Antibody tests for identification of current and past infection with SARS-CoV-2"},{"title3":"Estimating prevalence using an imperfect test"},{"title3":"REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: study protocol [version 1; peer review: awaiting peer review]"},{"title3":"Flower, B. et al. Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey. Thorax10.1136/thoraxjnl-2020-215732 (2020)."},{"title3":"Atchison, C. et al. Usability and acceptability of home-based self-testing for SARS-CoV-2 antibodies for population surveillance. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 10.1093/cid/ciaa1178 (2020)."},{"title3":"David, S., Shahab, L., Brown, J. &amp; Perski, O. The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: a living rapid evidence review (version 6). Qeios, 10.32388/UJR2AW.7 (2020)."},{"title3":"Public Health England. Weekly Coronavirus Disease 2019 (COVID-19) Surveillance Report: Summary of COVID-19 Surveillance Systems 2020. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/888254/COVID19_Epidemiological_Summary_w22_Final.pdf (2020)."},{"title3":"Office for National Statistics. Coronavirus (COVID-19) Infection Survey Pilot. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/12june2020 (2020)."},{"title3":"Rentsch, C. T. et al. Covid-19 by race and ethnicity: a National Cohort Study of 6 million United States Veterans. MedRxiv Prepr. Serv. Health Sci. 10.1101/2020.05.12.20099135 (2020)."},{"title3":"COVID-19 among American Indian and Alaska native persons:23 States, January 31-July 3, 2020"},{"title3":"Public Health England. Beyond the Data: Understanding the Impact of COVID-19 on BAME Groups. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/892376/COVID_stakeholder_engagement_synthesis_beyond_the_data.pdf (2020)."},{"title3":"Pastor-Barriuso, R. et al. SARS-CoV-2 infection fatality risk in a nationwide seroepidemiological study. medRxiv10.1101/2020.08.06.20169722 (2020)."},{"title3":"Streeck, H. et al. Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. medRxiv10.1101/2020.05.04.20090076 (2020)."},{"title3":"How deadly is the coronavirus? Scientists are close to an answer"},{"title3":"Kellam, P. &amp; Barclay, W. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection. J. Gen. Virol. 10.1099/jgv.0.001439 (2020)."},{"title3":"Comas-Herrera, A. et al. Mortality associated with COVID-19 outbreaks in care homes: early international evidence. Published on LTC Responses to COVID-19, International Long Term Care Policy Network. available at https://ltccovid.org/2020/04/12/mortality-associated-with-covid-19-outbreaks-in-care-homes-early-international-evidence/ (2020)."},{"title3":"Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility:King County, Washington, March 2020"},{"title3":"Oran, D. P. &amp; Topol, E. J. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann. Intern. Med. 10.7326/M20-3012 (2020)."},{"title3":"Farsalinos, K. et al. Editorial: nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicol. Rep. 10.1016/j.toxrep.2020.04.012 (2020)."},{"title3":"Riley, S. et al. Community prevalence of SARS-CoV-2 virus in England during May 2020: REACT study. medRxiv10.1101/2020.07.10.20150524 (2020)."},{"title3":"Ministry of Housing, Communities and Local Government. The English Indices of Deprivation 2019: Frequently Asked Questions (FAQs). https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/853811/IoD2019_FAQ_v4.pdf (2019)."},{"title3":"Office for National Statistics. Population Estimates for the UK, England and Wales, Scotland and Northern Ireland: mid-2019. www.ons.gov.uk/releases/populationestimatesfortheukenglandandwalesscotlandandnorthernirelandmid2019 (2020)."},{"title3":"Public Health England. Excess Mortality in England, week Ending 17 July 2020. https://fingertips.phe.org.uk/static-reports/mortality-surveillance/excess-mortality-in-england-week-ending-17-Jul-2020.html."},{"title3":"Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020"},{"title3":"R Core Team. R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing, Vienna, 2019)."},{"title3":"Office for National Statistics. Deaths Involving COVID-19 in the Care Sector, England and Wales: Deaths Occurring up to 12 June 2020 and Registered Up to 20 June 2020 (Provisional). https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/deathsinvolvingcovid19inthecaresectorenglandandwales/deathsoccurringupto12june2020andregisteredupto20june2020provisional (2020)."},{"title3":"Office for National Statistics. Number of Deaths in Care Homes Notified to the Care Quality Commission, England. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/numberofdeathsincarehomesnotifiedtothecarequalitycommissionengland (2020)."},{"title3":"Office for National Statistics. Research Report on Population Estimates by Characteristics. https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/methodologies/researchreportonpopulationestimatesbycharacteristics#data-sources (2020)."},{"title3":"Office for National Statistics. Communal Establishment Management and Type by Ethnic Group by Sex. http://www.nomisweb.co.uk/census/2011/dc4211ewla (2013)."},{"title3":"Office for National Statistics. Coronavirus (COVID-19) Related Deaths by Ethnic Group, England and Wales: 2 March 2020 to 15 May 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/coronaviruscovid19relateddeathsbyethnicgroupenglandandwales/2march2020to15may2020#ethnic-group-breakdown-of-covid-19-deaths-by-age-and-sex (2020)."},{"title3":"Office for National Statistics. Deaths Registered Weekly in England and Wales, Provisional. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/weeklyprovisionalfiguresondeathsregisteredinenglandandwales (2020)."}]},{"title2":"Systematic review of safety and efficacy of COVID-19 vaccines in patients with kidney disease","References":[{"title3":"Chronic Kidney Disease in the United States, 2019. Published online 2019"},{"title3":"Estimated County-Level Prevalence of selected underlying medical conditions associated with increased risk for severe COVID-19 illness : United States, 2018"},{"title3":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine"},{"title3":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine"},{"title3":"The Advisory Committee on Immunization Practices' updated interim recommendation for allocation of COVID-19 vaccine : United States, December 2020"},{"title3":"COVID-19 and racial/ethnic disparities"},{"title3":"Prophylactic vaccinations in chronic kidney disease: current status"},{"title3":"Practical guide to vaccination in all stages of CKD, including patients treated by dialysis or kidney transplantation"},{"title3":"Detection of SARS-CoV-2 antibodies in kidney transplant recipients"}]},{"title2":"Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients","References":[]},{"title2":"Coronavirus and vaccine hesitancy, Great Britain: 13 January to 7 February 2021","References":[]},{"title2":"SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness","References":[{"title3":"Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national data"},{"title3":"Cohort profile: early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database"},{"title3":"Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study"},{"title3":"First dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and haemorrhagic events in Scotland"},{"title3":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study"},{"title3":"Effectiveness of COVID-19 vaccines against the B.1.617.2 variant"}]},{"title2":"Effectiveness of Covid-19 vaccines against the B.1.617.2 (delta) variant","References":[]},{"title2":"Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application: a prospective, observational study","References":[{"title3":"Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe"},{"title3":"COVID-19: how does local lockdown work, and is it effective?"},{"title3":"Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'"},{"title3":"Universal weekly testing as the UK COVID-19 lockdown exit strategy"},{"title3":"A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys"},{"title3":"Rapid implementation of mobile technology for real-time epidemiology of COVID-19"},{"title3":"Community prevalence of SARS-CoV-2 in England during April to September 2020: results from the ONS Coronavirus Infection Survey"},{"title3":"REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: study protocol"},{"title3":"High prevalence of SARS-CoV-2 swab positivity in England during September 2020: interim report of round 5 of REACT-1 study"},{"title3":"Guidance: COVID-19 testing data: methodology note"},{"title3":"Real-time tracking of self-reported symptoms to predict potential COVID-19"},{"title3":"Geo-social gradients in predicted COVID-19 prevalence and severity in Great Britain: results from 2 266 235 users of the COVID-19 Symptoms Tracker app"},{"title3":"The English Indices of Deprivation 2019: technical report"},{"title3":"Real time Bayesian estimation of the epidemic potential of emerging infectious diseases"},{"title3":"Serial interval of novel coronavirus (COVID-19) infections"},{"title3":"Accessible data curation and analytics for international-scale citizen science datasets"},{"title3":"Community prevalence of SARS-CoV-2 in England: results from the ONS coronavirus infection survey pilot"},{"title3":"Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review"},{"title3":"The R number and growth rate in the UK"},{"title3":"Population-scale longitudinal mapping of COVID-19 symptoms, behaviour and testing"},{"title3":"COVID-19 testing in the UK"},{"title3":"Probable delirium is a presenting symptom of COVID-19 in frail, older adults: a cohort study of 322 hospitalised and 535 community-based older adults"},{"title3":"Racial and ethnic determinants of COVID-19 risk"},{"title3":"Collider bias undermines our understanding of COVID-19 disease risk and severity"}]},{"title2":"Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination, 30 December 2020","References":[]},{"title2":"Comparison of frailty screening instruments in the emergency department","References":[{"title3":"Increasing rates of emergency department visits for elderly patients in the United States, 1993 to 2003"},{"title3":"The world report on ageing and health: a policy framework for healthy ageing"},{"title3":"Identifying frailty in the emergency department-feasibility study"},{"title3":"Screening for frailty in elderly emergency department patients by using the identification of seniors at risk (ISAR)"},{"title3":"Risk factors and screening instruments to predict adverse outcomes for undifferentiated older emergency department patients: a systematic review and meta-analysis"},{"title3":"Frailty: implications for clinical practice and public health"},{"title3":"Management of frailty: opportunities, challenges, and future directions"},{"title3":"Clinical epidemiology: a new discipline for an old art"},{"title3":"Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments"},{"title3":"Frailty in older adults: evidence for a phenotype"},{"title3":"Accumulation of deficits as a proxy measure of aging"},{"title3":"What is the evidence for the management of patients along the pathway from the emergency department to acute admission to reduce unplanned attendance and admission? An evidence synthesis"},{"title3":"A global clinical measure of fitness and frailty in elderly people"},{"title3":"Novel frailty screening questionnaire (FSQ) predicts 8-year mortality in older adults in China"},{"title3":"A frailty screening questionnaire (FSQ) to rapidly predict negative health outcomes of older adults in emergency care settings"},{"title3":"A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans"},{"title3":"Frailty defined by FRAIL scale as a predictor of mortality: a systematic review and meta-analysis"},{"title3":"FRAIL scale: predictive validity and diagnostic test accuracy"},{"title3":"Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living"},{"title3":"Validation of the clinical frailty scale for prediction of thirty-day mortality in the emergency department"},{"title3":"Which frailty scale for patients admitted via emergency department? A cohort study"},{"title3":"Comparison of frailty screening instruments in the emergency department"},{"title3":"Comparison of three frailty scales for prediction of adverse outcomes among older adults: a prospective cohort study"},{"title3":"Does the clinical frailty scale at triage predict outcomes from emergency care for older people?"},{"title3":"Accuracy of the clinical frailty scale for perioperative frailty screening: a prospective observational study"},{"title3":"The role of illness acuity on the association between frailty and mortality in emergency department patients referred to internal medicine"},{"title3":"The clinical frailty scale and health services use for older adults in the emergency department"},{"title3":"Frailty and adverse outcomes in older adults being discharged from the emergency department: a prospective cohort study"},{"title3":"Operationalization of frailty using eight commonly used scales and comparison of their ability to predict all-cause mortality"}]}]},{"title1":"Novel coronavirus infection in children outside of Wuhan, China","References":[{"title2":"Coronavirus infections:more than just the common cold","References":[]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Recommendations for the diagnosis, prevention and control of the 2019 novel coronavirus infection in children","References":[]},{"title2":"Characteristics of COVID-19 infection in Beijing","References":[]},{"title2":"Coronavirus infections-more than just the common cold","References":[]},{"title2":"2019 Novel coronavirus:important information for clinicians","References":[]},{"title2":"Novel coronavirus infection in hospitalized infants under 1 year of age in China","References":[]},{"title2":"Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management","References":[{"title3":"World Health Organization. Acute respiratory syndrome in China. http://www.who.int/csr/don/2003_02_11/en/ (accessed 11 February 2003)."},{"title3":"Centers for Disease Control and Prevention. Severe acute respiratory syndrome (SARS). http://www.cdc.gov/ncidod/sars/ (accessed 7 May 2003)."},{"title3":"Centers for Disease Control and Prevention. Severe acute respiratory syndrome (SARS). http://www.cdc.gov/ncidod/sars/casedefinition.htm (accessed 20 May 2003)."},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"World Health Organization. WHO collaborative multi-centre research project on severe acute respiratory syndrome (SARS) diagnosis. http://www.who.int/csr/sars/project/en/ (accessed 9 May 2003)."},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory"},{"title3":"Nidovirales: a new order comprising Coronaviridae and Arteriviridae"},{"title3":"Siddell SG, Snijder EJ. Coronaviruses, toroviruses, and arteriviruses. In: Mahy BWJ, Collier L. (eds) Tropley and Wilson's Microbiology and Microbial Infections. London: Edward Arnold; 1998; 463-484."},{"title3":"The biology and pathogenesis of coronaviruses"},{"title3":"Centers for Disease Control and Prevention. Interpreting SARS test results. http://www.cdc.gov/ncidod/sars/testresultsc.htm (accessed 9 May 2003)."},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study"},{"title3":"Atypical presentations of SARS"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Severe acute respiratory syndrome (SARS): epidemiology, diagnosis and treatment"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus"},{"title3":"Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)"},{"title3":"World Health Organization. Hospital infection control guidance for severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/infectioncontrol/en/ (accessed 3 June 2003)."},{"title3":"World Health Organization. First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network. http://www.who.int/csr/sars/survival_2003_05_04/en/ (accessed 4 May 2003)."}]},{"title2":"Clinical presentations and outcome of severe acute respiratory syndrome in children","References":[{"title3":"Case definition for surveillance of severe acute respiratory syndrome SARS"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection"}]},{"title2":"Children hospitalized with severe acute respiratory syndrome-related illness in Toronto","References":[]},{"title2":"Epidemiological characteristics of 2143 pediatric patients With 2019 coronavirus disease in China","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","References":[]},{"title2":"Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study","References":[]},{"title2":"SARS in newborns and children","References":[{"title3":"Alterations of immunoglobulin G and immunoglobulin M levels in the breast milk of mothers with exclusive breastfeeding compared to mothers with non-exclusive breastfeeding during 6 months postpartum: the Jordanian cohort study"},{"title3":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis"},{"title3":"SARS-CoV-2 antibodies detected in mother's milk post-vaccination"},{"title3":"Maternal and infant outcomes associated with maternity practices related to COVID-19: the COVID mothers study"},{"title3":"Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine"},{"title3":"Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns"},{"title3":"Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study"},{"title3":"Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review"},{"title3":"Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19"},{"title3":"COVID-19 mRNA vaccine and antibody response in lactating women: a prospective cohort study"},{"title3":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2"},{"title3":"Changes in human milk immunoglobulin profile during prolonged lactation"},{"title3":"Coronavirus disease-19 deaths among children and adolescents in an area of Northeast, Brazil: why so many?"},{"title3":"Impact of pertussis-specific IgA, IgM, and IgG antibodies in mother's own breast milk and donor breast milk during preterm infant digestion"},{"title3":"European Medicines Agency. Comirnaty. https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu https://www.ema.europa.eu/en/medicines/human/summaries-opinion/comirnaty, 2020 (accessed on 29 december 2020)."},{"title3":"Robust and specific secretory IgA against SARS-CoV-2 detected in human milk"},{"title3":"COVID-19 mRNA vaccination in lactation: assessment of adverse events and vaccine related antibodies in mother-infant dyads"},{"title3":"The immune system of human milk: antimicrobial, anti-inflammatory and immunomodulating properties"},{"title3":"Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination"},{"title3":"Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study"},{"title3":"Anti-idiotypic antibodies to poliovirus antibodies in commercial immunoglobulin preparations, human serum, and milk"},{"title3":"Hare H, Womersley K. Healthcare workers who breastfeed should be offered the Covid-19 vaccine. https://blogs.bmj.com/bmj/2020/12/21/healthcare-workers-who-breastfeed-should-be-offered-the-covid-19-vaccine, 2020 (accesed on 15 january 2021)."},{"title3":"Joint Committee on Vaccination and Immunisation. COVID-19 vaccination: a guide for women of childbearing age, pregnant or breastfeeding, Updated 2021. https://www.gov.uk/government/publications/covid-19-vaccination-women-of-childbearing-age-currently-pregnant-planning-a-pregnancy-or-breastfeeding, 2021 (accesed on january 2022)."},{"title3":"Vertical transmission of Coronavirus disease 2019: a systematic review and meta-analysis"},{"title3":"No infectious SARS-CoV-2 in breast milk from a cohort of 110 lactating women"},{"title3":"Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis"},{"title3":"Correction to: SARS-COV-2 infection in children and newborns: a systematic review"},{"title3":"Breast milk prefusion F Immunoglobulin G as a correlate of protection against respiratory syncytial virus acute respiratory illness"},{"title3":"Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019-positive mothers and neonates at birth"},{"title3":"SARS-CoV-2-specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women"},{"title3":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine"},{"title3":"IgA and neutralizing antibodies to influenza A virus in human milk: a randomized trial of antenatal influenza immunization"},{"title3":"Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococcal vaccine: a randomized, controlled evaluation"},{"title3":"IgA dominates the early neutralizing antibody response to SARS-CoV-2"},{"title3":"Induction of mucosal immunity through systemic immunization: phantom or reality?"},{"title3":"Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age"},{"title3":"The Advisory Committee on Immunization Practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in children aged 5-11 years - United States, November 2021"}]},{"title2":"Clinical characteristics of 2019 novel coronavirus (2019-nCoV) infection in children and family prevention and control","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"}]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","References":[{"title3":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"SWISSMODEL: an automated protein homology-modeling server"},{"title3":"GISAID: Global initiative on sharing all influenza data:from vision to reality"}]},{"title2":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov","References":[]},{"title2":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","References":[{"title3":"Masters PS, Perlman, S (2013) Coronaviridae. In: Knipe DM, Howley P (eds) Fields Virology. Lippincott Williams and Wilkins, Philadelphia, PA, pp 825-858"},{"title3":"Coronavirus host range expansion and Middle East respiratory syndrome coronavirus emergence: biochemical mechanisms and evolutionary perspectives"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Coronavirus-associated pneumonia in previously healthy children"},{"title3":"Clinical disease in children associated with newly described coronavirus subtypes"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"van Boheemen S et al (2012) Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3(6)"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"WHO Cumulative number of reported probable cases of SARS. In: 2003"},{"title3":"http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_RA_20140613.pdf WUoM-CTfAtHaIRfA-RGLaoMAf"},{"title3":"WHO: Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical and laboratory findings of SARS in Singapore"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients"},{"title3":"Middle East respiratory syndrome"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"SARS: clinical virology and pathogenesis"},{"title3":"The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"van den Brand JM et al (2014) The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol 151(1):83-112"},{"title3":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Disease-promoting effects of type I interferons in viral, bacterial, and coinfections"},{"title3":"Age-dependent dysregulation of innate immunity"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome"},{"title3":"Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Chu H et al (2015) Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis 213(6):904-14"},{"title3":"Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus"},{"title3":"Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease"},{"title3":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Animal models for SARS and MERS coronaviruses"},{"title3":"Animal models of Middle East respiratory syndrome coronavirus infection"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"Cockrell A et al (2016) A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nature Microbiology 2:16226"},{"title3":"Li K et al (2017) Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proceedings of the National Academy of Sciences 114(15):E3119-E3128"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Interaction of SARS and MERS coronaviruses with the antiviral interferon response"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling"},{"title3":"Interferon and cytokine responses to SARS-coronavirus infection"},{"title3":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Fehr AR et al (2016) The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection. mBio 7(6):e01721-16"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism"},{"title3":"Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain"},{"title3":"Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3"},{"title3":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists"},{"title3":"Initial viral load and the outcomes of SARS"},{"title3":"Proliferative growth of SARS coronavirus in Vero E6 cells"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand"},{"title3":"Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia"},{"title3":"Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Adaptive immune cells temper initial innate responses"},{"title3":"Not so fast: adaptive suppression of innate immunity"},{"title3":"Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection"},{"title3":"Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Reghunathan R et al (2005) Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunology 6:2"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Zumla A et al (2016) Coronaviruses:drug discovery and therapeutic options. Nat Rev Drug Discov 15(5):327-47"},{"title3":"IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment"},{"title3":"IFN-lambda resolves inflammation via suppression of neutrophil infiltration and IL-1beta production"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury"},{"title3":"The TLR4 antagonist Eritoran protects mice from lethal influenza infection"},{"title3":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection"},{"title3":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus"},{"title3":"Silencing of CCR2 in myocarditis"},{"title3":"Therapeutic siRNA silencing in inflammatory monocytes in mice"},{"title3":"Immunomodulatory therapy for severe influenza"},{"title3":"The effect of inhibition of PP1 and TNFalpha signaling on pathogenesis of SARS coronavirus"}]}]},{"title1":"Clinical Features of 33 Cases in Children Infected With SARS-CoV-2 in Anhui Province, ChinaA Multi-Center Retrospective Cohort Study","References":[{"title2":"Axillary temperature compared to tympanic membrane temperature in children","References":[]},{"title2":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China[J]","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"}]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition)","References":[]},{"title2":"COVID-19 faecal-oral transmission: are we asking the right questions?","References":[{"title3":"First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community"},{"title3":"Editorial: handwashing with soap - a new way to prevent ARIs?"},{"title3":"A brief review on the possible role of houseflies and cockroaches in the mechanical transmission of coronavirus disease 2019 (COVID-19)"},{"title3":"Effectiveness of handwashing in preventing SARS: a review"},{"title3":"COVID-19: mitigating transmission via wastewater plumbing systems"},{"title3":"Survival of coronaviruses in water and wastewater"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents"},{"title3":"Detection of SARS-CoV-2 in Different Types of Clinical Specimens."},{"title3":"Consensus document on the epidemiology of severe acute respiratory syndrome (SARS)"},{"title3":"Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations"},{"title3":"Prolonged presence of SARS-CoV-2 viral RNA in faecal samples"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"}]},{"title2":"Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections","References":[{"title3":"Epidemic and emerging coronaviruses (severe acute respiratory syndrome and Middle East respiratory syndrome)"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Coronaviridae"},{"title3":"Another decade, another coronavirus"},{"title3":"Severe acute respiratory syndrome: Historical, epidemiologic, and clinical features"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Wuhan Seafood Market May Not Be Source of Novel Virus Spreading Globally"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV)"},{"title3":"Novel Coronavirus (2019-nCoV). Situation Report-20"},{"title3":"W.H.O. Declares Global Emergency as Wuhan Coronavirus Spreads"},{"title3":"Antepartum pneumonia in pregnancy"},{"title3":"Risk factors associated with the increasing prevalence of pneumonia during pregnancy"},{"title3":"Pneumonia during pregnancy: Has modern technology improved maternal and fetal outcome?"},{"title3":"Indirect obstetric deaths in the state of Michigan 1960-1968"},{"title3":"Pneumonia during pregnancy"},{"title3":"Emerging infections and pregnancy"},{"title3":"Immunobiologic adaptations of pregnancy"},{"title3":"Acute respiratory failure in pregnancy due to staphylococcal pneumonia"},{"title3":"Pregnancy and the lung"},{"title3":"Influenza occurring in pregnant women; a statistical study of thirteen hundred and fifty cases"},{"title3":"Observations on excess mortality associated with epidemic influenza"},{"title3":"Learning from SARS: Renewal of Public Health in Canada:SARS in Canada: Anatomy of an Outbreak"},{"title3":"Reporting Incidence of Severe Acute Respiratory Syndrome (SARS) Appendix A: Chronology"},{"title3":"Consensus Document on the Epidemiology of Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome and pregnancy"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Infection control for SARS in a tertiary neonatal centre"},{"title3":"SARS in newborns and children"},{"title3":"No. 225-Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS)"},{"title3":"A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome"},{"title3":"Clinical analysis of pregnancy in second and third trimesters complicated severe acute respiratory syndrome"},{"title3":"SARS and pregnancy: A case report"},{"title3":"SARS in pregnancy"},{"title3":"SARS during pregnancy, United States"},{"title3":"Severe acute respiratory syndrome in pregnancy"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome (SARS) in neonates and children"},{"title3":"The placentas of patients with severe acute respiratory syndrome: A pathophysiological evaluation"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome"},{"title3":"The SARS epidemic in Hong Kong: What lessons have we learned?"},{"title3":"Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS)"},{"title3":"Middle East Respiratory Syndrome (MERS) Background"},{"title3":"Middle East respiratory syndrome coronavirus infection during pregnancy: A report of 5 cases from Saudi Arabia"},{"title3":"Middle East Respiratory Syndrome (MERS) Fact Sheet"},{"title3":"MERS-CoV infection in pregnant woman in Korea"},{"title3":"Middle East Respiratory Syndrome (MERS) Overview"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Novel coronavirus infections in Jordan, April 2012: Epidemiological findings from a retrospective investigation"},{"title3":"2014 MERS-CoV outbreak in Jeddah:A link to health care facilities"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Middle East respiratory syndrome: What we learned from the 2015 outbreak in the Republic of Korea"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir"},{"title3":"Dromedary camels and the transmission of Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome"},{"title3":"An Overview of the latest infectious diseases around the world"},{"title3":"Middle East respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates 2013"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: Report of two cases &amp; review of literature"},{"title3":"Stillbirth during infection with Middle East respiratory syndrome coronavirus"},{"title3":"Update on therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Vertical transmission of human coronavirus. Prospective pilot study"},{"title3":"Materno-fetal transmission of human coronaviruses: A prospective pilot study"},{"title3":"Emerging respiratory viruses: Challenges and vaccine strategies"},{"title3":"Duration of antibody responses after severe acute respiratory syndrome"},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"},{"title3":"Clinical trials and administration of Zika virus vaccine in pregnant women: Lessons (that should have been) learned from excluding immunization with the Ebola vaccine during pregnancy and lactation"},{"title3":"Being pregnant during the Kivu Ebola virus outbreak in DR Congo: The rVSV-ZEBOV vaccine and its accessibility by mothers and infants during humanitarian crises and in conflict areas"},{"title3":"Maternal and infant death and the rVSV-ZEBOV vaccine through three recent Ebola virus epidemics-West Africa, DRC Equateur and DRC Kivu: 4 years of excluding pregnant and lactating women and their infants from immunization"},{"title3":"CEPI to Fund Three Programmes to Develop Vaccines against the Novel Coronavirus, nCoV-2019. 23 January 2020"},{"title3":"A Dozen Vaccine Programs Underway as WHO Declares Coronavirus Public Health Emergency. Biocentury. 30 January 2020"},{"title3":"WHO Target Product Profiles for MERS-CoV Vaccines"},{"title3":"When is it acceptable to vaccinate pregnant women? Risk, ethics, and politics of governance in epidemic crises"},{"title3":"Chinese Baby Tests Positive for Coronavirus 30 Hours after Birth"},{"title3":"A Pregnant Mother Infected with the Coronavirus Gave Birth, and Her Baby Tested Positive 30 Hours Later"},{"title3":"Coronavirus: Doctors Fear Pregnant Women Can Pass on Illness after Newborn Baby Is Diagnosed"},{"title3":"Expert Reaction to Newborn Baby Testing Positive for Coronavirus in Wuhan"},{"title3":"Zika virus infection in pregnancy, microcephaly and maternal and fetal health:What we think, what we know, and what we think we know"}]},{"title2":"Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children","References":[{"title3":"Coronaviruses: an overview of their replication and pathogenesis."},{"title3":"Bovine-like coronaviruses in domestic and wild ruminants."},{"title3":"Animal coronaviruses: what can they teach us about the severe acute respiratory syndrome?"},{"title3":"Epidemiological and clinical features of human coronavirus infections among different subsets of patients."},{"title3":"An outbreak of coronavirus OC43 respiratory infection in Normandy, France."},{"title3":"Human coronaviruses are uncommon in patients with gastrointestinal illness."},{"title3":"Detection of the new human coronavirus HKU1: a report of 6 cases."},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia."},{"title3":"Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease."},{"title3":"The differential clinical impact of human coronavirus species in children with cystic fibrosis."},{"title3":"Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China."},{"title3":"The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children."},{"title3":"Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus."},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A."},{"title3":"Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method."},{"title3":"Human coronaviruses and other respiratory infections in young adults on a university campus: prevalence, symptoms, and shedding."},{"title3":"Evidence supporting a zoonotic origin of human coronavirus strain NL63."},{"title3":"Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana."},{"title3":"Link of a ubiquitous human coronavirus to dromedary camels."},{"title3":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"A review of studies on animal reservoirs of the SARS coronavirus."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"SARS-CoV infection in a restaurant from palm civet."},{"title3":"Molecular epidemiology, evolution and phylogeny of SARS coronavirus."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group."},{"title3":"Genetic evidence of Middle East respiratory syndrome coronavirus (MERS-Cov) and widespread seroprevalence among camels in Kenya."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Coronavirus disease 2019 (COVID-19) Situation Report - 32."},{"title3":"Clinical disease in children associated with newly described coronavirus subtypes."},{"title3":"Burden and risk factors for coronavirus infections in infants in rural Nepal."},{"title3":"Respiratory viruses and influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample."},{"title3":"Acute viral respiratory infections among children in MERS-endemic Riyadh, Saudi Arabia, 2012-2013."},{"title3":"Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou."},{"title3":"Human coronavirus infections in Israel: epidemiology, clinical symptoms and summer seasonality of HCoV-HKU1."},{"title3":"Comparing nonpharmaceutical interventions for containing emerging epidemics."},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study."},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study."},{"title3":"Superspreading and the effect of individual variation on disease emergence."},{"title3":"Estimation of MERS-coronavirus reproductive number and case fatality rate for the spring 2014 Saudi Arabia outbreak: insights from publicly available data."},{"title3":"Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures."},{"title3":"Model parameters and outbreak control for SARS."},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission."},{"title3":"Predictive models of control strategies involved in containing indoor airborne infections."},{"title3":"Unraveling the drivers of MERS-CoV transmission."},{"title3":"MERS transmission and risk factors: a systematic review."},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak."},{"title3":"Mystery deepens over animal source of coronavirus."},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV), MERS Monthly Summary, November 2019."},{"title3":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 48."},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003."},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi."},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children."},{"title3":"Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong."},{"title3":"Children hospitalized with severe acute respiratory syndrome-related illness in Toronto."},{"title3":"Middle East respiratory syndrome coronavirus disease is rare in children: an update from Saudi Arabia."},{"title3":"[Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen]."},{"title3":"Incubation periods of acute respiratory viral infections: a systematic review."},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients."},{"title3":"Does SARS-CoV-2 has a longer incubation period than SARS and MERS?"},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan."},{"title3":"SARS: epidemiology."},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."},{"title3":"Middle East respiratory syndrome coronavirus outbreak in the republic of Korea, 2015."},{"title3":"Middle East respiratory syndrome."},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015."},{"title3":"Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia."},{"title3":"Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus."},{"title3":"Epidemiology of multiple respiratory viruses in childcare attendees."},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Middle East respiratory syndrome coronavirus in pediatrics: a report of seven cases from Saudi Arabia."},{"title3":"Novel coronavirus infection in hospitalized infants under 1 year of age in China."},{"title3":"Identification of a new human coronavirus."},{"title3":"Croup is associated with the novel coronavirus NL63."},{"title3":"The novel human coronaviruses NL63 and HKU1."},{"title3":"Update on human rhinovirus and coronavirus infections."},{"title3":"Seroepidemiologic studies of coronavirus infection in adults and children."},{"title3":"Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis."},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor."},{"title3":"A case-control study of SARS versus community acquired pneumonia."},{"title3":"Severe acute respiratory syndrome among children."},{"title3":"Severe acute respiratory syndrome (SARS): chest radiographic features in children."},{"title3":"[Analysis of CT features of 15 children with 2019 novel coronavirus infection]."},{"title3":"Severe acute respiratory syndrome (SARS) in neonates and children."},{"title3":"Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reaction."},{"title3":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome."},{"title3":"Genomic sequencing of the severe acute respiratory syndrome-coronavirus."},{"title3":"Genomic sequencing of a SARS coronavirus isolate that predated the Metropole Hotel case cluster in Hong Kong."},{"title3":"Evaluation of a Real-Time Reverse Transcription-PCR (RT-PCR) assay for detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in clinical samples from an outbreak in South Korea in 2015."},{"title3":"Analytical and clinical validation of six commercial Middle East respiratory syndrome coronavirus RNA detection kits based on real-time reverse-transcription PCR."},{"title3":"MERS-CoV diagnosis: an update."},{"title3":"WHO interim guidance on clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected."},{"title3":"Detection of human coronaviruses in simultaneously collected stool samples and nasopharyngeal swabs from hospitalized children with acute gastroenteritis."},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus."},{"title3":"Serology of severe acute respiratory syndrome: implications for surveillance and outcome."},{"title3":"Laboratory diagnosis of SARS."},{"title3":"[Serological analysis of SARS coronavirus in children diagnosed clinically as severe acute respiratory syndrome cases during SARS epidemic in Beijing]."},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study."},{"title3":"Fatal lower respiratory tract disease with human corona virus NL63 in an adult haematopoietic cell transplant recipient."},{"title3":"Human coronavirus NL-63 infection in a Brazilian patient suspected of H1N1 2009 influenza infection: description of a fatal case."},{"title3":"A novel coronavirus emerging in China - key questions for impact assessment."},{"title3":"Case fatality of SARS in mainland China and associated risk factors."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics."},{"title3":"Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study."},{"title3":"Case characteristics among Middle East respiratory syndrome coronavirus outbreak and non-outbreak cases in Saudi Arabia from 2012 to 2015."},{"title3":"Disease outbreak news. 24 February 2020. Middle East respiratory syndrome coronavirus (MERS-CoV) - The Kingdom of Saudi Arabia."},{"title3":"Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea."},{"title3":"National Health Commission of the People's Republic of China."},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention."},{"title3":"Epidemiology of coronavirus respiratory infections."},{"title3":"The Tecumseh study of respiratory illness. VI. Frequency of and relationship between outbreaks of coronavirus infection."},{"title3":"Human coronavirus NL63 and 229E seroconversion in children."},{"title3":"Prevalence of human coronavirus antibody in the population of southern Iraq."},{"title3":"Seroepidemiologic survey of coronavirus (strain OC 43) related infections in a children's population."},{"title3":"Epidemiology and clinical presentations of human coronavirus NL63 infections in hong kong children."},{"title3":"Newly identified respiratory viruses associated with acute lower respiratory tract infections in children in Lanzou, China, from 2006 to 2009."},{"title3":"Clinical manifestations of human coronavirus NL63 infection in children in Taiwan."},{"title3":"Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995."},{"title3":"Coronavirus HKU1 and other coronavirus infections in Hong Kong."},{"title3":"Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome."},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong."},{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission."},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk."},{"title3":"Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from multiple sclerosis patients."},{"title3":"Coronaviruses in spinal fluid of patients with acute monosymptomatic optic neuritis."},{"title3":"Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease."},{"title3":"Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan."},{"title3":"Initial viral load and the outcomes of SARS."},{"title3":"Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms."},{"title3":"Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction."},{"title3":"Radiological and pulmonary function outcomes of children with SARS."},{"title3":"Infants born to mothers with severe acute respiratory syndrome."},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome."},{"title3":"Surveillance and testing for Middle East respiratory syndrome coronavirus, Saudi Arabia, April 2015-February 2016."},{"title3":"Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study."},{"title3":"Stillbirth during infection with Middle East respiratory syndrome coronavirus."},{"title3":"Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome."},{"title3":"Middle East respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013."},{"title3":"Middle East respiratory syndrome coronavirus infection during pregnancy: a report of 5 cases from Saudi Arabia."},{"title3":"Evaluating and reporting persons under investigation (PUI)."},{"title3":"Global Surveillance for human infection with novel coronavirus (2019-nCoV)."},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China."},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records."},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome."},{"title3":"Viral loads in clinical specimens and SARS manifestations."},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43."},{"title3":"SARS: systematic review of treatment effects."},{"title3":"Clinical management and infection control of SARS: lessons learned."},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study."},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings."},{"title3":"Inflammatory cytokine profile in children with severe acute respiratory syndrome."},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study."},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study."},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus."},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset."},{"title3":"MERS CoV infection in two renal transplant recipients: case report."},{"title3":"Interim clinical guidance for management of patients with confirmed 2019 novel coronavirus (2019-nCoV) infection."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong."},{"title3":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein."},{"title3":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies."},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution."},{"title3":"Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection."},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients."},{"title3":"Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine."},{"title3":"Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models."},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus."},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC."},{"title3":"Human coronavirus HKU1 spike protein uses O-acetylated sialic acid as an attachment receptor determinant and employs hemagglutinin-esterase protein as a receptor-destroying enzyme."},{"title3":"Identification of six new polymorphisms in the human coronavirus 229E receptor gene (aminopeptidase N/CD13)."},{"title3":"Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2."},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry."},{"title3":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry."},{"title3":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds."},{"title3":"A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication."},{"title3":"Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV."},{"title3":"New insights into the antiviral effects of chloroquine."},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread."},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro."},{"title3":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430."},{"title3":"Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses."},{"title3":"Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the Middle East respiratory syndrome virus."},{"title3":"Antiviral activity of K22 against members of the order Nidovirales."},{"title3":"Broad-spectrum antiviral therapeutics."},{"title3":"Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine."},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses."},{"title3":"Variations in spike glycoprotein gene of MERS-CoV, South Korea, 2015."},{"title3":"Genetic diversity of MERS-CoV spike protein gene in Saudi Arabia."},{"title3":"Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry."},{"title3":"A highly immunogenic, protective, and safe adenovirus-based vaccine expressing Middle East respiratory syndrome coronavirus S1-CD40L fusion protein in a transgenic human dipeptidyl peptidase 4 mouse model."},{"title3":"Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets."},{"title3":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo."},{"title3":"A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters."},{"title3":"Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice."},{"title3":"Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice."},{"title3":"The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host."},{"title3":"Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate."},{"title3":"Middle East respiratory syndrome coronavirus nonstructural protein 16 is necessary for interferon resistance and viral pathogenesis."},{"title3":"Immunogenicity of SARS inactivated vaccine in BALB/c mice."},{"title3":"A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice."},{"title3":"A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses."},{"title3":"Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of Middle East respiratory syndrome coronavirus."},{"title3":"Immunization with inactivated Middle East respiratory syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus."},{"title3":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine."},{"title3":"Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys."},{"title3":"SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement."},{"title3":"The spike protein of SARS-CoV-a target for vaccine and therapeutic development."},{"title3":"Efficacy of an adjuvanted Middle East respiratory syndrome coronavirus spike protein vaccine in dromedary camels and alpacas."},{"title3":"Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection."},{"title3":"A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection."},{"title3":"Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: implication for designing novel mucosal MERS vaccines."},{"title3":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge."},{"title3":"The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection."},{"title3":"Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus."},{"title3":"Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate."},{"title3":"Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice."},{"title3":"Effects of a SARS-associated coronavirus vaccine in monkeys."},{"title3":"Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model."},{"title3":"Recombinant viruses as tools to induce protective cellular immunity against infectious diseases."},{"title3":"Safety and immunogenicity of a candidate MERS-CoV vaccine (MERS001)."},{"title3":"Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus."},{"title3":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice."},{"title3":"Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity."},{"title3":"Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS."},{"title3":"Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses."},{"title3":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies."},{"title3":"Type IVB pilus operon promoter controlling expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid gene in Salmonella enterica Serovar Typhi elicits full immune response by intranasal vaccination."},{"title3":"Evaluation of candidate vaccine approaches for MERS-CoV."},{"title3":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates."},{"title3":"Phase I, open label dose ranging safety study of GLS-5300 in healthy volunteers."},{"title3":"Evaluate the safety, tolerability and immunogenicity study of GLS-5300 in healthy volunteers."},{"title3":"Safety, tolerability and immunogenicity of vaccine candidate MVA-MERS-S."},{"title3":"Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea."},{"title3":"Infection control for SARS in a tertiary neonatal centre."},{"title3":"Infection control for SARS in a tertiary paediatric centre in Hong Kong."},{"title3":"Severe acute respiratory syndrome coronavirus on hospital surfaces."},{"title3":"Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination."},{"title3":"Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents."},{"title3":"Survival characteristics of airborne human coronavirus 229E."},{"title3":"Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1,286 of their close contacts. medRxiv 2020."}]},{"title2":"COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Coronavirus disease 2019 (COVID-19) Situation Report - 11."},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention."},{"title3":"Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1,286 of their close contacts."},{"title3":"Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"SARS-CoV-2 infection in children."},{"title3":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study."},{"title3":"A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features."},{"title3":"A retrospective study of the clinical characteristics of COVID-19 infection in 26 children."},{"title3":"Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults."},{"title3":"Detection of covid-19 in children in early january 2020 in Wuhan, China."},{"title3":"Novel coronavirus infection in hospitalized infants under 1 year of age in China."},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding."},{"title3":"Clinical characteristics of 34 children with coronavirus disease-2019 in the West of China: a multiple-center case series."},{"title3":"Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study."},{"title3":"Prolonged presence of SARS-CoV-2 in feces of pediatric patients during the convalescent phase."},{"title3":"A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage."},{"title3":"Clinical features of pediatric patients with COVID-19: a report of two family cluster cases."},{"title3":"A well infant with coronavirus disease 2019 (COVID-19) with high viral load."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"[2019 novel coronavirus infection in a three-month-old baby]."},{"title3":"[First case of 2019 novel coronavirus infection in children in Shanghai]."},{"title3":"Three children who recovered from novel coronavirus 2019 pneumonia."},{"title3":"Clinical and CT imaging features of the COVID-19 pneumonia: focus on pregnant women and children."},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series."},{"title3":"[Retracted: clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen]."},{"title3":"[Analysis of CT features of 15 Children with 2019 novel coronavirus infection]."},{"title3":"Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China."},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records."},{"title3":"Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study."},{"title3":"Infants Born to Mothers With a New Coronavirus (COVID-19)."},{"title3":"Perinatal transmission of COVID-19 associated SARS-CoV-2: should we worry?"},{"title3":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia."},{"title3":"Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy."},{"title3":"A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery."},{"title3":"Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China."},{"title3":"Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study."},{"title3":"Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn."},{"title3":"Antibodies in infants born to mothers with COVID-19 pneumonia."},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children."},{"title3":"Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong."},{"title3":"Children hospitalized with severe acute respiratory syndrome-related illness in Toronto."},{"title3":"Severe acute respiratory syndrome among children."},{"title3":"Middle East respiratory syndrome coronavirus disease is rare in children: an update from Saudi Arabia."},{"title3":"Middle East respiratory syndrome coronavirus in pediatrics: a report of seven cases from Saudi Arabia."},{"title3":"Evolution of the immune system in humans from infancy to old age."},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice."},{"title3":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection."},{"title3":"Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses."},{"title3":"Effects of ageing on the immune system: infants to elderly."},{"title3":"Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology."},{"title3":"Viral infection in the development and progression of pediatric acute respiratory distress syndrome."},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"Burden and risk factors for coronavirus infections in infants in rural Nepal."},{"title3":"Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample."},{"title3":"Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method."},{"title3":"Human coronavirus NL63 and 229E seroconversion in children."},{"title3":"Prevalence of human coronavirus antibody in the population of southern Iraq."},{"title3":"Seroepidemiologic survey of coronavirus (strain OC 43) related infections in a children's population."},{"title3":"Epidemiology and clinical presentations of human coronavirus NL63 infections in hong kong children."},{"title3":"Epidemiology of coronavirus respiratory infections."},{"title3":"The Tecumseh study of respiratory illness. VI. Frequency of and relationship between outbreaks of coronavirus infection."},{"title3":"Attenuation of influenza a virus disease severity by viral coinfection in a mouse model."},{"title3":"Virus-virus interactions impact the population dynamics of influenza and the common cold."},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study."},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses."},{"title3":"Should COVID-19 concern nephrologists? Why and to What Extent? The emerging impasse of angiotensin blockade."},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Antihypertensive drugs and risk of COVID-19?"},{"title3":"[Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives]."},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure."},{"title3":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections."},{"title3":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism."},{"title3":"A dynamic variation of pulmonary ACE2 is required to modulate neutrophilic inflammation in response to pseudomonas aeruginosa lung infection in mice."},{"title3":"Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang."},{"title3":"Association between circulating levels of ACE2-Ang-(1-7)-MAS axis and ACE2 gene polymorphisms in hypertensive patients."},{"title3":"Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study."},{"title3":"Non-specific effects of BCG vaccine on viral infections."},{"title3":"The impact of vaccines on heterologous adaptive immunity."},{"title3":"A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome."},{"title3":"Middle east respiratory syndrome coronavirus infection during pregnancy: a report of 5 Cases From Saudi Arabia."},{"title3":"Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis."},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome."},{"title3":"Infants born to mothers with severe acute respiratory syndrome."},{"title3":"Stillbirth during infection with Middle East respiratory syndrome coronavirus."},{"title3":"Impact of Middle East Respiratory Syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome."},{"title3":"Middle east respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013."}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China","References":[]},{"title2":"Importation and human-to-human transmission of a novel coronavirus in Vietnam","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."}]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures","References":[{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Hosts and sources of endemic human coronaviruses"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with Pneumonia in China, 2019"},{"title3":"Screening for influenza A(H1N1)pdm09, Auckland International Airport, New Zealand"},{"title3":"Clinical and epidemiologic characteristics of spreaders of middle east respiratory syndrome coronavirus during the 2015 outbreak in Korea"},{"title3":"Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"}]},{"title2":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","References":[{"title3":"Evaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses"},{"title3":"DNA vaccination: transfection and activation of dendritic cells as key events for immunity"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Antibody response and disease severity in healthcare worker MERS survivors"},{"title3":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia"},{"title3":"High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection"},{"title3":"Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals"},{"title3":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection"},{"title3":"SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex"},{"title3":"Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant"},{"title3":"Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T Lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Characteristics of traveler with Middle East respiratory syndrome, China, 2015"},{"title3":"The HLA-A2-supermotif: a QSAR definition"},{"title3":"The spike protein of SARS-CoV-a target for vaccine and therapeutic development"},{"title3":"Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC"},{"title3":"Vaccines for the prevention against the threat of MERS-CoV"},{"title3":"A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity"},{"title3":"Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells"},{"title3":"Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection"},{"title3":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses"},{"title3":"Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus"},{"title3":"Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses"},{"title3":"Improved transgenic mouse model for studying HLA class I antigen presentation"},{"title3":"Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling"},{"title3":"Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA"},{"title3":"Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States"},{"title3":"Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen"},{"title3":"Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus"},{"title3":"Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms"},{"title3":"Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"Identification of an epitope of SARS-coronavirus nucleocapsid protein"},{"title3":"Functional and structural definition of a clustering region of HLA-A2-restricted cytotoxic T lymphocyte epitopes"},{"title3":"The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes"},{"title3":"Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein"},{"title3":"Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development"},{"title3":"Characterization of human alphabetaTCR repertoire and discovery of D-D fusion in TCRbeta chains"},{"title3":"Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome"},{"title3":"Protective T-cell responses featured by concordant recognition of MERS-CoV-derived CD8+ T-cell epitopes and host MHC"},{"title3":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV"},{"title3":"Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV"},{"title3":"Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent"},{"title3":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial"},{"title3":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity"},{"title3":"Serological assays for emerging coronaviruses: challenges and pitfalls"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"The structure and function of CD26 in the T-cell immune response"},{"title3":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope"},{"title3":"Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice"},{"title3":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea"},{"title3":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients"},{"title3":"Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Specific serology for emerging human coronaviruses by protein microarray"},{"title3":"Geographic distribution of MERS coronavirus among dromedary camels, Africa"},{"title3":"Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity"},{"title3":"Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A comprehensive comparison of transmembrane domains reveals organelle-specific properties"},{"title3":"Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system"},{"title3":"MERS in South Korea and China: a potential outbreak threat?"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes"},{"title3":"Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats"},{"title3":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"From SARS coronavirus to novel animal and human coronaviruses"},{"title3":"Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes"},{"title3":"HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins"},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"},{"title3":"Middle East respiratory syndrome and severe acute respiratory syndrome"},{"title3":"Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein"},{"title3":"Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Serological study of an imported case of Middle East respiratory syndrome and his close contacts in China, 2015"},{"title3":"Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis"},{"title3":"T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia"},{"title3":"Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein"},{"title3":"Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen"},{"title3":"Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients"},{"title3":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Current advancements and potential strategies in the development of MERS-CoV vaccines"},{"title3":"Frequency, private specificity, and cross-reactivity of preexisting hepatitis C virus (HCV)-Specific CD8+ T cells in HCV-seronegative individuals: implications for vaccine responses"},{"title3":"Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus"},{"title3":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection"},{"title3":"Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8(+) T cells are augmented in varying degrees by CpG ODN, PolyI: C and R848"},{"title3":"CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein"},{"title3":"Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes"},{"title3":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"}]},{"title2":"CT imaging features of 2019 novel coronavirus (2019-nCoV)","References":[{"title3":"Novel Coronavirus - China. World Health Organization"},{"title3":"Novel Coronavirus (2019-nCoV). World Health Organization"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. World Health Organization"},{"title3":"Middle East respiratory syndrome Coronavirus (MERS-CoV). World Health Organization"},{"title3":"Situation report - 8. World Health Organization"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"Radiographic and CT Features of Viral Pneumonia"},{"title3":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Middle East respiratory syndrome-Coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"About 2019 Novel Coronavirus (2019-nCoV). Centers for Disease Control and Prevention"},{"title3":"Radiologic pattern of disease in patients with severe acute respiratory syndrome: the Toronto experience"}]},{"title2":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","References":[]},{"title2":"aging healthy, or with diabetes, is associated with ACE2/ACE this imbalance in the hematopoietic stem progenitor cells[J]","References":[]},{"title2":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","References":[]},{"title2":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Severe acute respiratory syndrome"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"The Pathology and Pathogenesis of Experimental Severe Acute Respiratory Syndrome and Influenza in Animal Models"},{"title3":"The Immunobiology of SARS*"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"SARS in Singapore--predictors of disease severity"},{"title3":"The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health"},{"title3":"Sex differences in immune responses"},{"title3":"Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity"},{"title3":"Sex-associated hormones and immunity to protozoan parasites"},{"title3":"Role of sex steroid hormones in bacterial-host interactions"},{"title3":"Sex hormones and the immune response in humans"},{"title3":"Sex differences in the recognition of and innate antiviral responses to Seoul virus in Norway rats"},{"title3":"Elevated 17beta-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses"},{"title3":"17beta-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs"},{"title3":"CD200 receptor controls sex-specific TLR7 responses to viral infection"},{"title3":"Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis"},{"title3":"The complex role of estrogens in inflammation"},{"title3":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men"},{"title3":"Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors"},{"title3":"Type I interferon is a therapeutic target for virus-induced lethal vascular damage"},{"title3":"Tamoxifen administration to mice"},{"title3":"Age-dependent dysregulation of innate immunity"},{"title3":"Implications of X-linked gene regulation for sex differences in disease pathogenesis (comment on DOI 10.1002/bies.201100047)"},{"title3":"The effects of hormones on sex differences in infection: from genes to behavior"},{"title3":"Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox"},{"title3":"Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1"},{"title3":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha signaling"},{"title3":"Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages"},{"title3":"Estrogen inhibits lipopolysaccharide-induced tumor necrosis factor-alpha release from murine macrophages"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Female gender, estrogen loss, and Sub-RPE deposit formation in aged mice"},{"title3":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8"}]},{"title2":"Sexual dimorphism in innate immunity","References":[{"title3":"Overview of the immune response"},{"title3":"Genetic influence on inflammation variables in the elderly"},{"title3":"C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci"},{"title3":"Trained immunity: A program of innate immune memory in health and disease"},{"title3":"Defining trained immunity and its role in health and disease"},{"title3":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes"},{"title3":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes"},{"title3":"Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity"},{"title3":"Metabolic Induction of Trained Immunity through the Mevalonate Pathway"},{"title3":"Heme induces innate immune memory"},{"title3":"Host and Environmental Factors Influencing Individual Human Cytokine Responses"},{"title3":"Sex-differences in the prevalence of Helicobacter pylori infection in pediatric and adult populations: Systematic review and meta-analysis of 244 studies"},{"title3":"Sexual inequality in tuberculosis"},{"title3":"Gender disparity in infections of Hepatitis B virus"},{"title3":"Sexual Dimorphism in Innate Immunity"},{"title3":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients"},{"title3":"The Xs and Y of immune responses to viral vaccines"},{"title3":"An immune clock of human pregnancy"},{"title3":"Trained Memory of Human Uterine NK Cells Enhances Their Function in Subsequent Pregnancies"},{"title3":"Sex hormones and the immune response in humans"},{"title3":"Signaling by nuclear receptors"},{"title3":"Rapid steroid hormone actions via membrane receptors"},{"title3":"Sex steroid receptors in immune cells"},{"title3":"Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations"},{"title3":"X-chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-mediated IFN-alpha production of plasmacytoid dendritic cells from women"},{"title3":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha signaling"},{"title3":"Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling"},{"title3":"Estrogen receptors regulate innate immune cells and signaling pathways"},{"title3":"The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases"},{"title3":"Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity"},{"title3":"The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathway"},{"title3":"Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo"},{"title3":"CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor"},{"title3":"Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERalpha36 and GPR30/GPER1"},{"title3":"NF-kappaB signaling in inflammation"},{"title3":"Nuclear Factor-kappaB in Autoimmunity: Man and Mouse"},{"title3":"The potential influence of breast cancer estrogen receptors' distribution on active DNA demethylation"},{"title3":"Membrane progesterone receptor beta (mPRbeta/Paqr8) promotes progesterone-dependent neurite outgrowth in PC12 neuronal cells via non-G protein-coupled receptor (GPCR) signaling"},{"title3":"Estrogen and progesterone receptor expression in macrophages and regulation of hepatocyte growth factor by ovarian steroids in women with endometriosis"},{"title3":"Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites"},{"title3":"Inhibitory effects of progesterone differ in dendritic cells from female and male rodents"},{"title3":"Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis"},{"title3":"Differential Modulation of TLR3- and TLR4-Mediated Dendritic Cell Maturation and Function by Progesterone"},{"title3":"Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors"},{"title3":"Androgen Receptor Structure, Function and Biology: From Bench to Bedside"},{"title3":"Androgen-Induced Immunosuppression"},{"title3":"Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes"},{"title3":"[17beta-Estradiol and testosterone influence the mRNA expression and the time course of inflammatory cytokines in activated human monocytic cell line (THP-1)]"},{"title3":"Testosterone Reduces Macrophage Expression in the Mouse of Toll-Like Receptor 4, a Trigger for Inflammation and Innate Immunity"},{"title3":"The effect of testosterone on cytokine production in the specific and non-specific immune response"},{"title3":"The impact of sex hormones on BCG-induced trained immunity"},{"title3":"The role of circulating sex hormones in menstrual cycle-dependent modulation of pain-related brain activation"},{"title3":"The complex role of estrogens in inflammation"},{"title3":"Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages"},{"title3":"Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity"},{"title3":"The inducible expression of THP-1 cell interleukin-1 mRNA: Effects of estrogen on differential response to phorbol ester and lipopolysaccharide"},{"title3":"Neutrophil extracellular traps: double-edged swords of innate immunity"},{"title3":"Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone"},{"title3":"Estrogen Modulates Inflammatory Mediator Expression and Neutrophil Chemotaxis in Injured Arteries"},{"title3":"Estrogens Augment Cell Surface TLR4 Expression on Murine Macrophages and Regulate Sepsis Susceptibility in Vivo"},{"title3":"Sexual dimorphism in bacterial infections"},{"title3":"Association of Sex With Clinical Outcome in Critically Ill Sepsis Patients: A Retrospective Analysis of the Large Clinical Database MIMIC-III"},{"title3":"Progesterone-Related Immune Modulation of Pregnancy and Labor"},{"title3":"Multimodal Regulation of NET Formation in Pregnancy: Progesterone Antagonizes the Pro-NETotic Effect of Estrogen and G-CSF"},{"title3":"Selective inhibition and augmentation of alternative macrophage activation by progesterone"},{"title3":"Progesterone rapidly down-regulates the biosynthesis of 5-lipoxygenase products in human primary monocytes"},{"title3":"The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review"},{"title3":"Chapter 11 - Role of Macrophages in Autoimmunity"},{"title3":"Sexual dimorphism in autoimmunity"},{"title3":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States"},{"title3":"Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan"},{"title3":"How does age at onset influence the outcome of autoimmune diseases"},{"title3":"Autoimmune diseases and reproductive aging"},{"title3":"Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice"},{"title3":"Suppression of the inflammatory response in experimental arthritis is mediated via estrogen receptor alpha but not estrogen receptor beta"},{"title3":"Treatment with an Estrogen Receptor alpha Ligand Is Neuroprotective in Experimental Autoimmune Encephalomyelitis"},{"title3":"The Anti-Inflammatory Effects of Testosterone"},{"title3":"Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice"},{"title3":"Effect of Castration on the Appearance of Diabetes in NOD Mouse"},{"title3":"A Protective Role For Testosterone In Adjuvant-Induced Arthritis"},{"title3":"Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells"},{"title3":"Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus"},{"title3":"Prolonged hypogonadism in male patients with rheumatoid arthritis during flares in disease activity"},{"title3":"Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation"},{"title3":"Free and serum testosterone levels in 276 males: a comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls"},{"title3":"Decreased testosterone levels in men with rheumatoid arthritis: effect of low dose prednisone therapy"},{"title3":"Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems"},{"title3":"Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation"},{"title3":"Gonadal hormones in men with rheumatoid arthritis-from onset through 2 years"},{"title3":"Bioavailable testosterone in men with rheumatoid arthritis-high frequency of hypogonadism"},{"title3":"High frequency of association of rheumatic/autoimmune diseases and untreated male hypogonadism with severe testicular dysfunction"},{"title3":"Systemic lupus erythematosus in men. Genetic and endocrine features"},{"title3":"Abnormalities of sex hormones in men with systemic lupus erythematosus"},{"title3":"Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus"},{"title3":"Systemic lupus erythematosus: sex hormones in male patients"},{"title3":"Evaluation of the hypothalamic-pituitary-gonadal axis in males with systemic lupus erythematosus"},{"title3":"Hormonal profiles and immunological studies of male lupus in Taiwan"},{"title3":"Profile of sex hormones in male patients with systemic lupus erythematosus"},{"title3":"Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus"},{"title3":"Penile anthropometry in systemic lupus erythematosus patients"},{"title3":"The neuroendocrine axis in patients with multiple sclerosis"},{"title3":"Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis"},{"title3":"Hypogonadism and the risk of rheumatic autoimmune disease"},{"title3":"A Higher Ratio of Estradiol to Testosterone Is Associated with Autoimmune Thyroid Disease in Males"},{"title3":"The relationship between circulating estradiol and thyroid autoimmunity in males"},{"title3":"Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival"},{"title3":"Sex Differences in the Blood Transcriptome Identify Robust Changes in Immune Cell Proportions with Aging and Influenza Infection"},{"title3":"Sex differences in the human peripheral blood transcriptome"},{"title3":"ImmGen report: sexual dimorphism in the immune system transcriptome"},{"title3":"Integrative analysis of methylome and transcriptome in human blood identifies extensive sex-and immune cell-specific differentially methylated regions"},{"title3":"Adaptation and memory in immune responses"},{"title3":"Perceptions of epigenetics"},{"title3":"Latent enhancers activated by stimulation in differentiated cells"},{"title3":"Transcriptional and epigenetic regulation of macrophages in atherosclerosis"},{"title3":"beta-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance"},{"title3":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity"},{"title3":"Human monocyte-to-macrophage differentiation involves highly localized gain and loss of DNA methylation at transcription factor binding sites"},{"title3":"Extensive epigenomic integration of the glucocorticoid response in primary human monocytes and in vitro derived macrophages"},{"title3":"Epigenetics of estrogen receptor signaling: role in hormonal cancer progression and therapy"},{"title3":"Steroid hormones regulate genome-wide epigenetic programming and gene transcription in human endometrial cells with marked aberrancies in endometriosis"},{"title3":"Global DNA methylation changes spanning puberty are near predicted estrogen-responsive genes and enriched for genes involved in endocrine and immune processes"},{"title3":"Pubertal development in healthy children is mirrored by DNA methylation patterns in peripheral blood"},{"title3":"DNA Methylation Trajectories During Pregnancy"},{"title3":"The Cellular Transcriptome in the Maternal Circulation During Normal Pregnancy: A Longitudinal Study"},{"title3":"Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy"},{"title3":"Transient epigenomic changes during pregnancy and early postpartum in women with and without type 2 diabetes"},{"title3":"Effect of Menopause on Gene Expression Profiles of Circulating Monocytes: A Pilot in vivo Microarray Study"},{"title3":"Hormone Replacement Therapy Associated White Blood Cell DNA Methylation and Gene Expression are Associated With Within-Pair Differences of Body Adiposity and Bone Mass"},{"title3":"Effects of Ageing on the Immune System: Infants to Elderly"},{"title3":"T-cell subsets in healthy teenagers: Transition to the adult phenotype"},{"title3":"Immune Function in Healthy Adolescents"},{"title3":"Hormones in pregnancy"},{"title3":"Human Chorionic Gonadotropin as a Pivotal Endocrine Immune Regulator Initiating and Preserving Fetal Tolerance"},{"title3":"Mechanism of human chorionic gonadotrophin-mediated immunomodulation in pregnancy"},{"title3":"Shifts in the TH1/TH2 Balance during Human Pregnancy Correlate with Apoptotic Changes"},{"title3":"The Th1:th2 dichotomy of pregnancy and preterm labour"},{"title3":"Modulations of Cytokine Expression in Pregnant Women"},{"title3":"The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions"},{"title3":"Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions"},{"title3":"Pregnancy-specific down-regulation of NF-kappa B expression in T cells in humans is essential for the maintenance of the cytokine profile required for pregnancy success"},{"title3":"The pro-inflammatory and anti-inflammatory cytokine profile in peripheral blood of women with recurrent implantation failure"},{"title3":"Regulatory T cells mediate maternal tolerance to the fetus"},{"title3":"Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset"},{"title3":"Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice"},{"title3":"Influence of reproductive hormones on the induction of CD4(+)CD25 (bright)Foxp (3+) regulatory T cells"},{"title3":"Immune Modulatory Effects of Human Chorionic Gonadotropin on Dendritic Cells Supporting Fetal Survival in Murine Pregnancy"},{"title3":"Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy"},{"title3":"Human Chorionic Gonadotropin modulates CXCL10 Expression through Histone Methylation in human decidua"},{"title3":"The contribution of macrophages to normal and pathological pregnancies"},{"title3":"Gene Expression Profiling of Human Decidual Macrophages: Evidence for Immunosuppressive Phenotype"},{"title3":"In-depth characterization of monocyte subsets during the course of healthy pregnancy"},{"title3":"Innate immune responses to toll-like receptor stimulation are altered during the course of pregnancy"},{"title3":"Endotoxin-induced cytokine production of monocytes of third-trimester pregnant women compared with women in the follicular phase of the menstrual cycle"},{"title3":"The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro"},{"title3":"Estrogen-dependent regulation of human uterine natural killer cells promotes vascular remodelling via secretion of CCL2"},{"title3":"The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a Listeria monocytogenes infection"},{"title3":"Progesterone Enhances Interleukin-15 Production in Human Endometrial Stromal Cells in Vitro1"},{"title3":"The remission of rheumatoid arthritis during pregnancy"},{"title3":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group"},{"title3":"Immunity, thyroid function and pregnancy: molecular mechanisms"},{"title3":"How pregnancy can affect autoimmune diseases progression"},{"title3":"Obstetric outcome in systemic lupus erythematosus"},{"title3":"Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies"},{"title3":"Estradiol-17beta-Induced Changes in the Porcine Endometrial Transcriptome In Vivo"},{"title3":"The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study"},{"title3":"Reproductive hormones and the menopause transition"},{"title3":"Effects of Sex Hormones and Age on Brain Volume in Post-Menopausal Women"},{"title3":"Hormone replacement therapy and the prevention of postmenopausal osteoporosis"},{"title3":"Global gene expression profiles in skeletal muscle of monozygotic female twins discordant for hormone replacement therapy"},{"title3":"Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Postmenopausal Women"},{"title3":"Distinct DNA methylation profiles in bone and blood of osteoporotic and healthy postmenopausal women"},{"title3":"The relationship between testosterone and molecular markers of inflammation in older men"},{"title3":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases"},{"title3":"Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination"},{"title3":"Hormone therapy for trans and gender diverse patients in the general practice setting"},{"title3":"Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study"},{"title3":"What does the &quot;four core genotypes&quot; mouse model tell us about sex differences in the brain and other tissues"},{"title3":"A primer on the use of mouse models for identifying direct sex chromosome effects that cause sex differences in non-gonadal tissues"},{"title3":"The number of x chromosomes causes sex differences in adiposity in mice"},{"title3":"Sex differences in diurnal rhythms of food intake in mice caused by gonadal hormones and complement of sex chromosomes"},{"title3":"Significant symptomatic improvement of subacute cutaneous lupus after testosterone therapy in a female-to-male transgender subject"},{"title3":"Lupus erythematosus tumidus induced by sex reassignment surgery"},{"title3":"Development of systemic lupus erythematosus in a male-to-female transsexual: the role of sex hormones revisited"},{"title3":"New-onset lupus nephritis after male-to-female sex reassignment surgery"},{"title3":"Effects of sex steroids on the pattern of methylation and expression of the promoter region of estrogen and androgen receptors in people with gender dysphoria under cross-sex hormone treatment"},{"title3":"Transgender Women on Feminizing Hormone Therapy Demonstrate a Distinct Rectal Mucosal Transcriptome from Cisgender Men"},{"title3":"BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner"},{"title3":"Personalized vaccinology: one size and dose might not fit both sexes"}]},{"title2":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections","References":[]},{"title2":"Novel coronavirus infection in hospitalized infants under 1 year of age in China","References":[]},{"title2":"A new coronavirus associated with human respiratory disease in China","References":[]},{"title2":"Three emerging coronaviruses in two decades the story of SARS, MERS, and now COVID-19","References":[]}]}]}